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I
n the pages of this edition of Medicine + Health, you will 
recognize that much is happening at the GW School 
of Medicine and Health Sciences (SMHS). Since the 
beginning of the year, when we published the new 
strategic plan for SMHS, we have established the impetus for 
momentum and growth in key strategic areas. The first goal of 
our strategic plan focuses on leadership — that is, to promote 
a culture of excellence through leadership, performance 
improvement, professionalism, and diversity and inclusion for 
students, residents, faculty, and staff. 
Over the past few months, we have welcomed many new 
faces to our roster of leaders. Some of these leaders are dedicated 
to the fight against cancer, such as Eduardo Sotomayor, M.D., 
who has been tapped to lead the GW Cancer Center, and Ed 
Seto, Ph.D., who will lead basic science efforts for the center. 
Cancer research and clinical care will continue to be an 
important target for growth and will continue to evolve under 
Dr. Sotomayor’s leadership. I encourage you to support our 
efforts as we build aggressively in this area.
In addition, SMHS has appointed three new chairs. In 
September, we welcomed nationally recognized Raj Rao, M.D., 
as the new chair of the Department of Orthopedic Surgery. In 
the Health Sciences, we selected Margaret Plack, Ed.D., DPT, 
PT, to lead the innovative and entrepreneurial Department of 
Clinical Research and Leadership; and Karen Wright, Ph.D., 
PA-C, to lead the highly regarded Department of Physician 
Assistant Studies. In the M.D. program, we have continued 
to build out our leadership team under Richard Simons, 
M.D., senior associate dean for M.D. programs, by welcoming 
Katherine Chretien, M.D., as the new assistant dean for student 
affairs. 
You will read about each one of these new leaders in the 
pages of this magazine. We are very excited to have such a breadth 
of talent and expertise leading this great institution. 
Sincerely,
JEFFREY S. AKMAN, M.D. ’81, RESD ’85
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SCHOOL OF MEDICINE &
HEALTH SCIENCES
By advancing our four-part mission — to 
teach, heal, discover, and serve — the School 
of Medicine and Health Sciences (SMHS) 
seeks to change lives and better mankind. 
SMHS offers a challenging and formative 
educational experience designed to train 
leaders in a swiftly changing health care 
landscape.
SMHS is part of the George Washington 
University‘s $1 billion philanthropic 
campaign to support students, enhance 
academics, and break new ground through 
capital projects and research.
Your gift enables SMHS to have an impact in 
the community, the country, and the world.
Join us in making history.
go.gwu.edu/makehistorysmhs
Support the School 
of Medicine &
Health Sciences
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I attended this evening’s (June 9) 
Frontiers in Medicine lecture spon-
sored by GW’s School of Medicine and 
Health Sciences. At the check-in table, 
there were issues of the latest Medicine 
+ Health magazine. The cover picture 
of Jehan “Gigi” El-Bayoumi, M.D., 
immediately caught my eye. I count 
Dr. El-Bayoumi as a friend. She was my 
mother’s internist from late 2005 to her 
death in September 2014. 
I first met Dr. El-Bayoumi through 
another friend, Marie Borum, M.D. 
She was immediately friendly and 
seemed like a good person to know. 
In 2005 my mother had a stroke. For a 
week she stayed in Harper Hospital in 
Detroit, where she lived. I contacted 
Gigi from Detroit, explained the situa-
tion, and asked her to take my mother 
as a patient when we returned to 
Washington, D.C. 
Gigi provided my mother with 
excellent care. She was always compas-
sionate, never rushed (even when 
busy), and she always explained things 
to my mother in a way she could 
understand. Gigi gave my mother the 
same level of care that she would have 
wanted for her mother. 
There were occasions when Mom 
needed to be seen by specialists. The 
doctors that Gigi referred us to were 
excellent. They all worked together so 
that Mom got the best care — particu-
larly in late 2011 when she became 
anemic, began to lose weight, and 
ultimately was diagnosed with multiple 
myeloma. From then until the summer 
of 2014, we saw many GW doctors, and 
Mom had a great medical team. 
Last summer, Gigi saw Mom for 
the last time. It was clear to both of 
us that my mother was failing. I had 
some end-of-life questions, and Gigi 
answered them forthrightly and with 
SPRING 2015
Jehan El-Bayoumi, M.D., RESD ’88,  
dedicates herself to delivering 
medical care for all
HEALTH EQUITY
TO THE EDITOR,
compassion. One thing she said gave 
me great strength over the next couple 
of months. “You will not be alone in 
your decision-making,” she said. That 
meant a lot to me then, and it means a 
lot to me now. 
—June Jeffries
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For budding health care professionals, the simplicity of the 
white coat belies its symbolism: not only does it mark the 
start of a career, but it also represents the responsibility that 
accompanies care. “Superman has his cape, Spiderman’s 
got his tights, and I’ve got my white coat,” explained speaker 
Michael Kahn, a second-year medical student at the GW 
School of Medicine and Health Sciences (SMHS), at the M.D. 
White Coat and Honor Code Ceremony on Aug. 8. “To those 
we serve, it’s a symbol of healing, knowledge, and trust. And 
for those reasons, it carries with it immense power.”
Kahn’s words tugged at a narrative thread that wove 
through the speeches at the White Coat and Honor Code 
Ceremony for the nearly 200 members of the Class of 2019. 
Major General Nadja West, M.D. ’88, joint staff surgeon and 
ceremony keynote speaker, explained that “I wear the cloth 
of our nation in my uniform, but the threads of my white coat 
are embedded in the fibers of this uniform here.”
For the physician assistant students, who formally 
donned their coats at the Convocation and Short White Coat 
Ceremony in late June, the addition to their wardrobe signi-
fied a willingness to carry their patients’ burdens. “The most 
important thing it symbolizes to your patient is that you’ll 
listen to them, and you will join them in carrying whatever it 
is they brought in to lay before you,” said Susan LeLacheur, 
Dr.P.H. ’08, M.P.H. ’89, B.S. ’80, associate professor of physi-
cian assistant studies at SMHS. Keynote speaker Robert 
McNellis, PA ’91, M.P.H. ’91, who assured students that the 
white coat is the first in a lineup of milestones, encour-
aged the Class of 2017 to “embrace this experience; it’s a 
wonderful opportunity for you.”
MAKING THE ROUNDS
The Fabric of Health Professionals’ Lives
Rounding out the formal donning of the white coat, the 
new class of physical therapy (PT) students received their 
coats at the PT Convocation Ceremony in late October. 
“The White Coat Ceremony is a symbolic milestone, and it’s 
especially important right now for our first-year students, 
who have just embarked on their professional journey,” said 
Joyce Maring, DPT, Ph.D., program director for the Doctor 
of Physical Therapy Program, chair and associate professor 
in the Department of Physical Therapy and Health Care 
Sciences. “It promises to be a rewarding journey, but it’s one 
of enormous responsibility, so thankfully we don’t make that 
journey alone.” With those words, the second- and third-year 
PT students, as is tradition, helped the first-year students put 
on their coats for the first time.   
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Inspiration at Graduation
Inspirational messages from student 
speakers, keynote speakers, and 
GW School of Medicine and Health 
Sciences (SMHS) faculty blended with 
the sound of bagpipes at the M.D. and 
Health Sciences graduation ceremo-
nies on May 16 and 17.
The M.D. program Class of 
2015 received advice from keynote 
speaker Vice Admiral Vivek H. Murthy, 
M.D., M.B.A., the 19th U.S. surgeon 
general. “It’s an honor to be here at 
GW’s Rodham Institute 
Hosts Third Annual Summit
Health equity is a pervasive theme in 
discussions between health care workers 
and advocates across the country 
and around the globe, but it is also a 
matter of critical importance here in 
Washington, D.C.; despite its position 
as the nation’s capital, the city is home 
to some of the country’s most medic-
cally underserved neighborhoods. The 
on-going dialogue on health equity 
continued during the third annual 
Rodham Institute Summit, at THEARC in 
southeast Washington, D.C. Oct. 2.
The Rodham Institute, housed at 
GW’s School of Medicine and Health 
Sciences (SMHS) and supported by 
the GW Medical Faculty Associates, 
was founded in 2013 in honor of the 
late Dorothy Rodham and seeks to 
apply the transformative power of 
education to achieve health equity in 
Washington, D.C. This year’s summit, 
themed “Celebrating Great Work in Our 
GW because of this institute’s long-
standing commitment to creating 
physician citizens,” said Murthy. “Your 
leadership, your vision, your creativity, 
and your courage will be essential in 
creating an America that is as good at 
preventing illness as it is at treating it.”
Jeffrey S. Akman, M.D. ’81, RESD 
’85, vice president for health affairs at 
GW, Walter A. Bloedorn Professor of 
Administrative Medicine, and dean of 
SMHS, took a moment to remember 
Navdeep S. Kang, M.D. ’15, who died 
in August 2014 during his fourth-year 
of medical school. “He will forever be 
connected to this university through 
the Navdeep S. Kang Award for 
Excellence and Service established by 
his parents; the Navdeep S. Kang Class 
of 2015 Scholarship, supported by his 
classmates; and the Navdeep S. Kang 
Student Lounge in Ross Hall,” Akman 
said. Justin Michael Palanci, M.D. ’15, 
Community: Health 
Equity Success Stories,” 
included panels on 
front-line health care 
and mental health, a 
poster presentation, 
and a panel on child-
hood obesity featuring 
Chelsea Clinton, vice 
chair of the Clinton 
Foundation.
“I’m just so grateful 
that the work that the 
Rodham Institute and 
GW are doing now is in the same line 
that everyone should be able to deter-
mine their own paths, and that so often 
things like childhood obesity really are 
questions of social justice and equity,” 
Clinton said.
The day-long event also included a 
speech by former Senator Chris Dodd, 
a workshop by Deborah Johnson, 
and the 2015 Academic Community 
Collaborative Award ceremony, during 
which Jehan “Gigi” El-Bayoumi, M.D., 
RESD ’88, founding director of the insti-
tute and professor of medicine at SMHS, 
awarded three grants totaling $35,000 
to collaborative projects.
“This summit was not only about 
celebrating the great work that’s being 
done every day by silent heroes in our 
community that lifts people so that they 
can be healthier and able to lead happier 
lives,” said El-Bayoumi. “It’s also about 
sharing and exchanging experiences and 
maximizing the collective work being 
done to improve our city’s health.”  
was the first to receive the award.
The Health Sciences graduation, 
meanwhile, recognized the program’s 
culture of academic excellence among 
its cadre of students. Traditionally, SMHS 
recognizes the academic achievement 
and service of its students at the gradu-
ation ceremony, but this year stood out 
because so many students were worthy 
of recognition. In addition to honoring 
recent graduates who had served in the 
military and those earning inductions 
into honor society Alpha Eta, SMHS 
faculty recognized three outstanding 
students: Cassie Robertson, who 
earned a bachelor’s degree in phar-
macogenomics and was awarded the 
Outstanding Undergraduate Award; 
Angela Vince, M.A., who received the 
Outstanding Graduate Student Award; 
and Elizabeth Prevou, PA-C, M.P.H., who 
also accepted the Outstanding Graduate 
Student Award.  
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When a 7.4-magnitude earthquake 
struck Nepal in late April, the Fairfax 
County Urban Search and Rescue team 
had just begun its annual three-day 
exercise; after news of the devastation 
spread, the team grabbed its equip-
ment — luckily already prepared — and 
jumped on an airplane. 
As soon as the 57 volunteers, 
including Bruno Petinaux, M.D., RESD 
’02, associate professor of emer-
gency medicine at the GW School 
of Medicine and Health Sciences 
(SMHS), and medical director Anthony 
Macintyre, M.D., RESD ’96, professor of 
emergency medicine at SMHS, and six 
dogs landed, they got to work. While 
structural engineers and specially 
trained squads assessed the feasi-
bility of rescue attempts, Petinaux and 
Macintyre worked to sustain the lives of 
those entombed. 
“Some of these extrications can 
take many hours, so, initiating the care 
as soon as we can, is vital,” Macintyre 
said.
There When the Earth Moves GW SMHS Opens 
Dermatology Residency
The GW School of Medicine and Health 
Sciences (SMHS) has reopened its 
residency doors for a new specialty: 
dermatology. The program, which 
began in July 2015, enrolls two resi-
dents each year who will master the 
medical, surgical, and histopatho-
logical components of dermatology 
while working with a multicultural and 
socially diverse patient population in 
Washington, D.C.
“GW and Washington, D.C. create 
an ideal environment for residents to 
develop the skills necessary to thrive 
in any medical setting,” said Adam 
Friedman, M.D., associate professor 
of dermatology, dermatology resi-
dency program director, and director 
of translational research in the 
Department of Dermatology at SMHS. 
“It’s my goal to help develop future 
dermatologists through our rigorous 
and supportive teaching environment 
and innovative research initiatives, 
and by example of excellence in 
patient care.”
The curriculum includes compre-
hensive instruction and exposure in 
medical dermatology, dermatologic 
surgery, pediatric dermatology, 
dermatopathology, consultative 
inpatient dermatology, and several 
subspecialty areas. Residents will 
rotate through ambulatory clinics and 
inpatient consultation services at the 
GW Medical Faculty Associates and 
the GW Hospital; the Washington, D.C. 
VA Medical Center; and Children’s 
National Health System. They also 
will attend clinical conferences and 
lectures led by faculty from both SMHS 
and the surrounding metropolitan 
medical community.  
The physicians, who must grapple 
with access to their patients and a 
ticking clock of survivability, evaluate 
the injuries, which span the spectrum 
between minor cuts and bruises and 
major life-threatening trauma, such as 
“crush syndrome.”
“Any time you take a large amount 
of muscle mass and put pressure on 
it for a sustained period, you begin to 
kill that muscle mass,” Macintyre said. 
“Then when you remove that pressure, 
it can release toxins into the blood-
stream that can cause you to get sick 
very quickly.”
The rescue team, known as USA-1 
on its international deployment, 
achieved several successful rescues, 
including that of 15-year-old Pembe 
Tamang, who had been trapped under 
a hotel parking garage. His emer-
gence from the rubble was a triumph 
for the teams involved. Petinaux and 
Macintyre, however, sum up their 
efforts simply. “[We’re] just one piece 
of the puzzle,” Petinaux said.   
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From Here to Monrovia: Tackling Ebola
For the physicians and physician assistants tending to Ebola 
patients in Monrovia, Liberia, the line between survival 
and death was opaque. “You never knew who was going to 
survive,” said Brian Burt, PA-C ’03, B.A. ’96. “One day you’d 
go see the patient, and they’d be in complete renal failure 
with massive, life-threatening electrolyte disturbances, just 
unable to talk, incontinent. Then the next time  you’d come 
back, they’d be nearly turned around. On the other hand, 
you’d have somebody that was doing great and motoring 
along, and the next day you’d come, they’d be dead.”
Burt, along with GW School of Medicine and Health 
Sciences (SMHS) classmate Mark McKinnon, PA-C ’03, 
deployed with the United States Public Health Service 
Commissioned Corps to Monrovia to provide care to health 
care workers infected by Ebola. Conditions were hot and 
humid, and comforts were minimal. Given that needlestick 
injuries carried a nearly 100 percent infection rate, their 
Ebola treatment unit had a constant rotation of patients, 
some from the same family.  
Families also made up a number of patients for 
Colleen Kovach, M.D., clinical instructor of emergency 
A Path to the Future
The immersion of the GW School of 
Medicine and Health Sciences (SMHS) 
DC Health and Academic Preparation 
Program’s (DC HAPP) Cohort 3 into 
medicine began with a white coat 
ceremony.
“It’s really just symbolic of the fact 
that we take this opportunity to partici-
pate in your future. Your future success 
and your careers very seriously,” said 
Yolanda Haywood, M.D., RESD ’87, 
B.S. ’81, associate dean for diversity, 
inclusion, and student affairs; associate 
medicine at SMHS, who treated Ebola-infected Liberians. 
On one of her first days in the country, she encountered 
the body of a 7-year-old boy; he’d died hours before, and 
Kovach had to inform his mother, also stricken with Ebola 
and in a bed next to her son.
Despite the heartache, the trio of volunteers left with 
memories of survivors, survivor ceremonies — colorful 
ribbons tied to a tree, yellow handprints slapped on a blue 
wall — and a desire to keep helping. 
“I love the humanitarian response,” said Kovach, who 
also served along the Turkey–Syria border in summer 
2015. “I’m hoping to make a career out of it.”  
professor of emergency medicine; and 
overseer of DC HAPP. With a hug and 
smile, she held up white coats as the 13 
participants — all students from local 
high schools and charter schools — slid 
them on. “I hope you remember this 
when you go to med school,” Haywood 
added to participant Kevin Peralta.
“This program is perfect for me,” 
Peralta said later. “No one in my family 
— or anyone I know — is a doctor, so I 
wanted to surround myself with people 
who had the same goals and the same 
ambition that I did.”
Peralta, with Cohort 3, learned 
the ins and outs of a medical educa-
tion in the month-long program. 
Highlights included trips to the VA 
Medical Center, the Gross Lab, the 
birthing simulation lab, and students 
were certified in CPR. 
“Now that I’ve done this program, 
I feel like it really turned on my passion 
for medicine,” Peralta said after learning 
how to suture in the WISE lab.  
6 MEDICINE + HEALTH   |   FALL 2015
The GW School of Medicine and 
Health Sciences (SMHS) has launched 
a Ph.D. program in translational health 
sciences. The program is designed to 
prepare health care professionals and 
leaders to create, translate, dissemi-
nate, and integrate knowledge across 
disciplines. As a result, graduates 
will be prepared to improve health 
care practice and research, posi-
tively influence health policies, and 
develop the next generation of health 
professionals.
 “We are pleased that we are able 
to provide this specialized education to 
address a major need in our health and 
education systems,” said Joe Bocchino, 
Ed.D., M.B.A., senior associate dean for 
health sciences at SMHS. “Right now, 
new discoveries are made; however, 
they take too long to reach the public 
and affect complex health conditions 
that require a sustained and wide-
spread response. 
“Our goal,” Bocchino continued, 
“is to create a field of experts and 
educators who understand how 
to expedite the process and inte-
grate science from the bench to the 
bedside.”
The program, which is directed 
toward licensed health professionals 
and clinicians, health care administra-
tors, public health professionals, and 
educators, focuses on three areas: 
expanding translational research, 
improving health care practice, and 
advancing the development of educa-
tors who support the medical and 
health professions. The Ph.D. requires 
52 credits beyond a master’s degree, 
as well as completion of two compre-
hensive examinations, a proposal 
defense, and a defended dissertation. 
Students will participate in courses 
online and spend two weekends per 
semester at the Virginia Science & 
Technology Campus.
LINK: smhs.gwu.edu/translational-
health-sciences/  
New Ph.D. Program Prepares Experts to  
Translate Science into Solutions
Changing Career Course
Hopeful medical students without a 
background in general and organic 
chemistry, biology, physics, and 
biochemistry have an opportunity to 
buttress their educational foundations 
before applying to medical school. 
In summer 2015, GW’s School of 
Medicine and Health Sciences (SMHS) 
began admitting students for its new 
Post-Baccalaureate Pre-Medicine 
Program at GW’s Virginia Science 
& Technology Campus (VSTC). The 
program helps students prepare 
for the medical admissions process, 
including the interview and the newly 
designed MCAT exam.
When Pope Francis visited 
Washington, D.C. Sept. 22–24, the 
nation’s capital paused. Even Congress 
broke from its usual schedule to listen 
as the pontiff addressed a rare joint 
session. Being in Washington, D.C. 
means the GW School of Medicine 
and Health Sciences (SMHS) commu-
nity gets a front row seat on the 
action. Oftentimes, it also means 
SMHS is called upon to support that 
action. For the papal visit, a team 
of SMHS students, residents, and 
physicians from the Department 
of Emergency Medicine provided 
medical support during the Pope’s 
mass at the Catholic University and on 
the National Mall when he addressed 
Congress.
The SMHS team covered the 
events as part of the GW Medical 
Faculty Associates Medical Reserve 
Corp, a federally recognized medical 
response team, under the authority 
of the U.S. Department of Health 
and Human Services and the D.C. 
Department of Health. The team 
may be called upon to assist at mass 
gatherings, national security events, 
public health crises, and regional 
disasters.  
“This program is designed to 
provide candidates with the founda-
tional course work, standardized test 
preparation, and access to real-world 
experience necessary for a successful 
matriculation into medical school,” 
said Lisa S. Schwartz, Ed.D., program 
director of the Post-Baccalaureate 
Pre-Medicine Program. “This is the next 
step for someone who wants to change 
careers and pursue his or her goal of 
becoming a physician.”
The program, part of a continuing 
expansion of the health sciences 
programs at SMHS, features faculty 
mentors and 7,000 square feet of labo-
ratory and support space at VSTC.   
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Illuminating
Pediatric
Dysphagia
Genetic mouse model takes 
center stage as researchers  
investigate feeding and  
swallowing disorder
BY CAROLINE TRENT-GURBUZ
“C
an you imagine,” says Anthony-Samuel 
LaMantia, Ph.D., director of the GW 
Institute for Neuroscience and professor of 
pharmacology and physiology at the GW 
School of Medicine and Health Sciences (SMHS), “you’re an 
infant, and one of the key behaviors you have to learn is to 
ingest food. Someone comes at you with food, and it hurts! It 
makes you hurt.” That pain, a product of pediatric dysphagia, 
is at the heart of what LaMantia and his team — a veritable 
A-list troupe of basic science investigators — are working to 
solve. With a five-year, three-pronged plan and a $6.2 million 
program project grant (PPG) from the Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, 
PPG director LaMantia is determined to tackle the problem 
where it begins: in the brain. That’s where our story starts.
Act One: The Basics
Pediatric dysphagia, a swallowing and feeding disorder, 
presents as a mostly mechanical problem; infants and children 
are unable to chew and swallow and may aspirate or choke 
on what they try to consume. Complications include ear and 
sinus infections and dribbles of liquid that settle in the lungs. 
There’s also some suggestion that the scent and texture of 
food may be unpleasant or aversive, a result of disrupted 
sensory and olfactory modalities.
Today, dysphagia is treated symptomatically. There is no 
cure, and researchers understand little about a disorder that 
ranges from mild to severe. What researchers do know is that 
it can appear in as many as one in four children, and that up 
to 80 percent of those with neurodevelopmental disorders, 
such as autism, have dysphagia. “This is a real-life disease,” 
LaMantia says.
Dysphagia is also a tricky disease. As LaMantia points out, 
delving deeper into the “whys” and “hows” of a disorder that 
appears in babies has limitations; researchers and physicians 
would prefer using minimally invasive techniques with infants. 
The ideal solution, therefore, is an animal model.
Act Two: The Mouse Model
LaMantia has dedicated the past 15 years to DiGeorge 
Syndrome, or 22q11.2 Deletion Syndrome, which occurs when a 
small part of chromosome 22’s long arm is missing. The effects 
are far-reaching; patients suffer from a medley of compli-
cations: heart defects, cleft palates, autism or intellectual 
disabilities, and pediatric dysphagia. LaMantia’s research on 
DiGeorge Syndrome — and the genetic mouse model he and 
his team use — unlocked the link between the deletion and the 
resulting dysphagia.
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“It is remarkable how good a model this is,” LaMantia 
says. “The insight that we were initially able to get supported 
our basic hypothesis.”
That hypothesis, based on past research for eye 
movement disorders, was that dysphagia emerges when funda-
mental mechanisms in early brain development are disrupted, 
causing defects in the neurons that become part of the cranial 
nerve system. As a result, craniofacial formation and asso-
ciated swallowing and feeding apparatuses are negatively 
affected. The discovery, outlined in a 2013 study published 
in Disease Models & Mechanisms, revealed that dysphagia 
develops embryonically, not after a baby is born. With that 
in mind, the researchers at GW and clinical partner institu-
tion Children’s National Health System (Children’s National) 
decided to use the mouse model as a platform for further 
understanding dysphagia.
Act Three: The Team
To best tackle the causes of dysphagia, LaMantia and PPG 
associate director Sally Moody, Ph.D., professor of anatomy 
and regenerative biology at SMHS, assembled a cast of experts 
in mouse genetics, bioinformatics, maternal nutrition, and 
neuronal functioning.
“The project was put together to try to attack the problem, 
or at least analyze the problem, from a multidisciplinary 
perspective,” Moody explains. “We all have very different back-
grounds and training, and we put together three big projects 
that are combining all of those aspects. It’s the combination of 
expertise that we think will allow us to make progress.”
Act Four: The Project
The investigation is divided into three parts: the origin of 
dysphagia, the pathology, and a possible path to prevention, 
all of which researchers will pursue simultaneously while 
informing one another of their progress.
Part one, headed by David Mendelowitz, Ph.D., vice chair 
and professor of pharmacology and physiology at SMHS, with 
Norman Lee, Ph.D., professor of pharmacology and physiology at 
SMHS; Thomas Maynard, Ph.D., associate research professor of 
pharmacology and physiology at SMHS; and Anastas Popratiloff, 
M.D., Ph.D., adjunct professor of anatomy and regenera-
tive biology at SMHS. The team is focusing on dysphagia in 
newborns. More specifically, the researchers will assess any 
abnormalities in the neuroanatomical connections that control 
the muscles an animal uses to feed and swallow. “Are the neurons 
that have to control muscular contraction the right size?” 
LaMantia asks. “Do they have the right synaptic inputs?”
One experimental strategy that has shed light — literally 
— on certain aspects of dysphagia is a technique similar to a 
barium swallow. Using a contrast agent, in this case a fluores-
cent dye, mixed with formula, Maynard has been able to track 
the path of the liquid as it passes through both the normal and 
the genetically altered mice. In normal mice, some drops of dye 
collect in the crevices of the tongue, but most passes through 
the mouth en route to the stomach.
“In contrast, in a couple of mutants that we’ve tried, we see 
a whole bunch left in the mouth,” Maynard says. “If you look in 
the sinuses, there is food that they tried to swallow but that was 
kicked back up into the nasal regions.”
In another indication of the mutant animals’ difficulty 
in eating and swallowing, the researchers have found that the 
mutants also grow at a slower pace than their non-mutant siblings. 
In part two, LaMantia, Moody, and Lee are zeroing in 
on the development of the embryonic hindbrain. In early 
developmental stages, a population of cells migrates from the 
hindbrain into the periphery to make craniofacial structures. 
For infants with dysphagia, somewhere along the way the 
mechanisms controlling how these cells develop into periph-
eral neurons and the facial skeleton go awry. “The brain has 
to have a code, and the periphery has to have a code, and 
they have to match,” LaMantia says. When they don’t match, 
messaging between the two becomes garbled. A second 
important goal of the part-two team is to identify the genes 
that are altered in the hindbrain that lead to the motor and 
sensory mismatches.
The third part of the project is what LaMantia and Moody 
term the most adventurous. Retinoic acid, a derivative of 
Vitamin A, is one of the signaling factors strongly affected by 
the 22q11.2 deletion. Hypothesizing that maternal nutrition — 
in particular retinoic acid as it plays a role in the development 
of the hindbrain — could influence the severity of dysphagia, 
Irene Zohn, Ph.D., associate professor of pediatrics at SMHS 
and a researcher at Children’s National, along with Maynard, is 
experimenting with maternal diets.
“We’ve shown that with this particular mouse model, 
Vitamin A can modify phenotypes,” Zohn says. “So the goal of 
my project is to determine how changing the Vitamin A — having 
either borderline deficiency or too much Vitamin A — might alter 
the severity of feeding phenotypes.”
Act Five: The Goals
Although the team is still a few years away from the project’s 
conclusion, the researchers’ goals could have long-lasting 
consequences for dysphagia sufferers, some of whom cope with 
the disease well into adulthood.
“We’re hoping that there might be ways of regulating 
[dysphagia] either prenatally via diet or postnatally through 
pharmacological therapies to help the kids overcome this 
behavioral deficit that really impacts their lives,” Moody 
says. “Also, we think if we can figure out the problem with 
this syndrome, the information may be applicable to other 
syndromes where children also show dysphagia.”  
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This year marked the 150th anniversary of one of the most monumental events in Washington, D.C. history, and indeed U.S. history: the assassination of Abraham Lincoln. The tragic event cemented 
the George Washington University School of Medicine and 
Health Sciences (SMHS), or National Medical College of 
Columbian University, as it was known at the time, in its unoffi-
cial role as the health care provider to the world’s leaders. 
The following is a timeline of events based on National 
Archive records and accounts from Elmer Louis Kayser’s 
1973 history of the George Washington University’s 
academic medical programs, titled “A Medical Center: The 
Institutional Development of Medical Education in George 
Washington University.”
On April 14, 1865, just five days removed from the uncon-
ditional surrender of Confederate forces and six weeks after 
his second inauguration, President Abraham Lincoln and 
first lady Mary Todd Lincoln join others in a private box at 
Ford’s Theatre to watch a performance of the comedy “Our 
American Cousin.” Also in attendance is Maryland native and 
Confederate-sympathizer John Wilkes Booth. 
At 10:13 p.m., Booth enters the private box and pulls the 
trigger on a .44 caliber, single-shot derringer pistol aimed at 
the back of the president’s head. During his escape, Booth 
produces a knife and stabs U.S. Army officer Henry Rathbone, 
who was attending the play with the Lincolns and his fiancée, 
Clara Harris, the daughter of New York Senator Ira Harris.
First on the scene to aid the president is 23-year-old 
Charles Leale, M.D., who has only weeks before completed his 
medical training. Through physical examination, Leale deter-
mines a bullet has penetrated Lincoln’s skull just behind his left 
ear. The president is left paralyzed and barely breathing. 
Albert Freeman Africanus King, M.D. 1861, a graduate of 
the National Medical College of Columbian College, is seated 
below the president’s box in the orchestra section. King, just 24 
years old, will go on to become professor and chair of obstetrics 
and serve as dean of the National Medical College from 1879 to 
1894. He climbs to the box above, joining Leale in an effort to 
revive the president. After a medical examination, the young 
physicians help carry the president across 10th Street to the 
home of William Peterson. 
Lincoln’s personal physician, Robert King Stone, M.D., 
a faculty member at National Medical College and former 
dean of the medical faculty (1853), is summoned to Lincoln’s 
deathbed. Upon arrival, Stone assumes the role of chief 
attending physician for the mortally wounded president. 
John Frederick May, M.D., professor of surgery and 
anatomy and another former dean of National Medical College, 
is called to Lincoln’s bedside for consultation. Twelve days 
later, May will be called upon to help identify the body of John 
Wilkes Booth.
Nine hours after the shooting, at 7:22 a.m. on April 15, 
Lincoln dies. At his bedside, Secretary of War Edwin Stanton 
remarks, “Now he belongs to the ages.”  
Caring for a President
BY THOMAS KOHOUT
“I just want to say one word to you. Just one word. Plastics. There is a great future in plastics.” So goes an early scene in the 1967 Mike Nichols classic The Graduate. The pitch from a seasoned 
executive attempting to recruit the young college graduate 
played by Dustin Hoffman is an ideal symbol for the rapidly 
changing 1960s. It also alludes to the exponential growth in 
the use of, and reliance on, the synthetic polymer. Seemingly 
overnight, the use of plastics exploded in the mid-20th century, 
and soon a host of polymers could be found in everything from 
textiles to food packaging and even medical supplies. But plas-
tics’ rapid acceptance and widespread use posed a potentially 
serious problem. 
At least that’s what Ronald Brown, a toxicologist for 
the FDA, considered a possibility. In 2008, he asked Narine 
Sarvazyan, Ph.D., professor of pharmacology and physiology 
at GW’s School of Medicine and Health Sciences (SMHS) to 
collaborate on a toxicity project. Few at the time could imagine 
that it would lead to a scientific odyssey that continues to this 
day. Brown wanted to confirm whether there were potential 
cardiovascular problems associated with the chemical makeup 
of certain types of plastics regularly used in medical devices, 
specifically a chemical called Di-2-ethylhexyl phthalate 
(DEHP). Sarvazyan and her team then decided that the best 
approach to start would be to test whether DEHP had any 
harmful effects on isolated heart cells. 
Like the Hoffman character, Nikki Gillum Posnack, 
Ph.D. ’09, then a fourth-year graduate student in Sarvazyan’s 
lab, was dealing with the pressures of the rapidly approaching 
end to her doctoral training. Tasked with analyzing the cardiac 
effects of plastics, Posnack was skeptical, thinking it might not 
be the best use of her remaining time as a student. “We were 
interested in seeing if some of these plastic components could 
have adverse heart effects,” recalls Posnack, now an assistant 
research professor of pharmacology and physiology at SMHS. 
“There was very little available research on this chemical. So, 
we treated heart cells with a dose of a DEHP that mimicked a 
young patient’s exposure in the clinical setting. But, we did not 
observe any immediate effects of DEHP in our experiment.” 
BY ERIC BUTTERMAN
Posnack could have stopped with the initial tests and 
perhaps considered the matter closed. But a decision to put the 
treated heart cells into an incubator changed everything. 
The research team was startled to see that over time, 
arrhythmias began forming in the cardiac cell preparations. 
“Cells in your heart should be well coupled to allow for fast 
and uniform electrical conduction,” explains Posnack. “But 
these heart cells were communicating and beating on their 
own, independently of one another.”
After the discovery, not surprisingly, further testing was 
done, and by this time enthusiasm had replaced Posnack’s 
skepticism.
Posnack is now a first author on six peer-reviewed articles 
detailing adverse effects of plasticizers on heart physiology. 
She expanded her initial DEHP studies to also examine the 
influence of Bisphenol A (BPA), another plastic component, on 
heart cells and the heart as a whole. “Starting at low doses, we 
saw slowing of electrical conduction,” she says. “We detected 
both slowing of conduction velocity across the heart and 
delayed conduction between the atria and the ventricles.”
Posnack explains that BPA is usually found in polycarbon-
ates — shatterproof plastics, food and beverage containers, 
and as a liner in aluminum cans. Global production of BPA, 
according to Merchant Research and Consulting, reached 4.6 
million tons in 2013. In other words, people around the world 
come in contact with BPA on a daily basis.
“There is not a whole lot of information on whether these 
plastic chemicals are affecting the cardiovascular system,” 
she says. “We know we’re being exposed to these chemicals 
on a routine basis … it’s clearly a public health concern. Public 
health studies have recently shown associations between expo-
sure to plastic chemicals and adverse cardiac effects, but we do 
not have a whole lot of basic science research to show if those 
effects are directly linked or not.”
Leading the Way
What Posnack once considered a dull assignment now accounts 
for a significant portion of her professional hours. The reluc-
tant graduate student is now an enthusiastic research professor 
playing a lead role in plastic-related health care studies. And, 
as the mother of two children under 6, she has found that 
her efforts to uncover plastic’s effects, particularly related to 
childhood development, have grown into an obsession. “Look 
around,” she says. “Plastics and families go hand in hand. As I 
child, I remember drinking out of small juice glasses, but now 
it’s hard to find something that is not made of plastic. I’ll admit 
that we’ve switched to stainless steel bottles for our kids. … If 
my husband sees someone microwaving something in plastic, 
he tells them ‘glass is the way to go.’ But, even with those 
precautions, children don’t have a lot of wood or natural toys 
anymore. Everything is plastic. You can’t avoid it.”
Exposure levels for people who are undergoing bypass 
surgery or receiving blood transfusions are much higher than 
typical, says Posnack, explaining that the procedures “involve a 
good amount of plastic tubing or storage bags.” 
Now a full year into a K99 grant, she’s also started a collab-
orative study with Paul Marvar, Ph.D., assistant professor of 
pharmacology and physiology at SMHS, to explore the in vivo 
effects. “We’ve started to record electrocardiogram and blood 
pressure measurements at low dose exposures using radiote-
lemetry,” she explains. Human studies “have linked higher 
DEHP and/or BPA exposures with having high blood pressure, 
decreased heart-rate variability, and an increased risk of heart 
attack. With this telemetry system, we can look at the direct 
link between exposure and alterations in heart rate and blood 
pressure over time.”
Sarvazyan, Posnack’s mentor and co-author, considers 
her protegée’s work to be vitally important and assesses her as 
just the person to see it through. “Imagine your loved one goes 
to the hospital, and they have an underlying cardiovascular 
problem,” she says. “Then these chemicals migrate out of plastic 
medical devices into their blood, exaggerating what is already a 
dangerous situation. Dr. Posnack has already shown that high 
concentrations of BPA and DEHP can negatively affect the 
hearts of small animals, and she is fully set to understand the 
effects of clinically relevant concentrations of these compounds. 
“Moreover,” adds Sarvazyan, “she can now test the effects 
of these compounds on a person’s own cardiac myocytes, 
which can be derived from a small blood sample using induced 
pluripotent stem cells technology. ”
But while Posnack pushes on, she keeps in mind the value 
that plastics have grown to represent in society. It’s why, she 
says, we have to understand how best to use them — as opposed 
to eliminating them.
“Plastics are very important, and they save people’s lives 
every day in hospital settings,” she says. “We’re not trying 
to rid the world of plastic, but we are trying to get a better 
understanding of the risk and [figure out] if, in some case, there 
are alternatives that may be better. People need to remember 
these chemicals are also found in things other than plastic. 
BPA can also be found in aluminum cans, and it can be used in 
thermally printed cash register receipt paper. Yes, DEHP is a 
plasticizer, but phthalate chemicals can also be used in many 
personal care products with fragrances, such as shampoo. 
Many people don’t understand how far this reaches.” 
Despite the possible outcomes, Posnack knows that on her 
way to the truth, part of her job is not to scare people unneces-
sarily. “For those in science, many want to know what level of 
concern there should be, but it’s hard to walk an intermediate 
line and not be an alarmist,” she says. “But that’s a challenge 
you have to take on. … I’m hoping the results I find are helpful 
— no matter what they ultimately tell us.”  
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lthough he speaks in measured tones, Eduardo M. 
Sotomayor, M.D., director of the new GW Cancer 
Center (GWCC), exudes optimism and determina-
tion as he describes his vision for the institution: 
“Driving research innovation, personalized cancer care, and 
cancer policy from the nation’s capital.” He scrolls through 
a PowerPoint presentation, recently given to the GW Board 
of Trustees, and points out his regular caveat, “Not related to 
SCOTUS Judge Sonia Sotomayor.” He laughs before returning 
to his institutional mission, an inclusive and expansive 
approach to cancer.
GWCC will act as an umbrella, he explains, 
encompassing various facets of cancer care, from basic, trans-
lational, and clinical research to policy (“It’s my pet project,” 
he confides) and advancements in treatment. He plans to 
recruit talent from both inside and outside GW, creating a 
powerful task force for cancer. His more immediate goals 
include earning a prestigious National Cancer Institute 
(NCI) designation. The demands are rigorous, but not 
unfamiliar for a man who frequently transforms the phrase “I 
think I want to do this” into reality.
From the Beginning
Sotomayor, who readily describes himself as a physician-scientist, 
started his journey in medicine at age 7, during a trip to the 
hospital to be treated for an infection; he was fascinated by 
the health care providers’ compassion. Visits from an uncle, 
a medical student, cemented his desire to pursue medicine. 
“At that point, with these two experiences together, I said, ‘I 
think that I want to be a doctor,’” Sotomayor recalls, a smile 
spreading across his face at the memory. “My mom said, ‘Are 
you sure?’ and I said, ‘I want to be a doctor.’”
The ensuing years saw Sotomayor power through secondary 
and post-secondary school in his native Peru, culminating in 
graduation from Federico Villarreal Medical School in Lima. 
He worked for one year in the Peruvian countryside — part of 
a payback agreement with the government for a tuition-free 
education — before relocating to Fort Lauderdale, Florida. His 
initial area of interest was rheumatology.
“I was able to meet Dr. Diana Lopez,” Sotomayor says. 
“She is an immunologist, but she was not working on autoim-
mune disorders. She was not working in rheumatology. She was 
working in cancer. I had a meeting with her and said, ‘OK, I 
think this is what I want to do.’”
For Diana Lopez, Ph.D., professor of microbiology and 
immunology and director of the undergraduate program 
at the University of Miami Miller School of Medicine, 
Sotomayor was a memorable colleague, making his subse-
quent rise through medicine no surprise to her. “He 
impressed me so much,” she says. “He really is amazing. 
Hardworking, intelligent, dedicated.”
Sotomayor worked with Lopez for three years before he 
felt the need to return to clinical medicine. “He wanted to 
do his training as a medical doctor, because that’s what he 
was,” Lopez explains. “He did it here at Jackson Memorial 
[Hospital], and then he wanted to go and do more research.”
Sotomayor landed at Johns Hopkins University in 1995, 
where he joined a group of oncology researchers working 
under Hyam Levitsky, M.D. “They were passionate, and 
they truly believed that one day cancer immunology would 
be an area that would provide effective cancer treatments,” 
Sotomayor says. “So I said, ‘OK, I think I want to be part of 
this group.’ ” The researchers were tackling the role of healing 
T-cells and their ability to destroy cancer cells. Sotomayor 
narrowed his focus to lymphoma, specifically analyzing the 
interaction between T-lymphocytes and cancer cells, and the 
growth of cancerous tumors. Despite skepticism at the time, 
he was confident in cancer immunotherapy as a revolutionary 
approach to treatment.
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“In 2015, everybody loves cancer immunology,” Sotomayor 
says. “Everybody’s a believer because in the last five years, we’ve 
had many successes. Everybody wants to be a cancer immunol-
ogist now.” He adds, jokingly: “I’m kind of a pioneer.”
Pioneering Cancer Research and Treatments
As part of his proposed scientific program for GWCC, 
Sotomayor intends to explore cancer immunology and 
immunotherapy; his initial plans include expanding ongoing 
T-cell clinical trials at Children’s National Health System and 
further developing a cell therapy lab and stem cell transplant 
program at GW Hospital. He also wants to incorporate the 
promising fields of cancer epigenetics and microbial oncology, 
the latter of which pulls in Doug Nixon, Ph.D., Walter G. 
Ross Professor of Basic Science Research, chair and professor 
in the Department of Microbiology, Immunology, and 
Tropical Medicine at the GW School of Medicine and Health 
Sciences. Nixon is one of the aforementioned internal talents 
Sotomayor is tapping to head crucial research.
“I believe in internal recruitment,” Sotomayor says. “The 
[researchers, scientists, and engineers] are going to be focusing 
on areas that a few years from now, we can claim that we are the 
leaders in.”
Finding a Niche
Sotomayor’s resolve to earn the NCI designation is, like his 
decision to emphasize cancer immunology and research, reflec-
tive of his past experience. Four years after joining the team 
at Johns Hopkins, Sotomayor felt the balmy winds of Florida 
calling him back.
“I met Eduardo when he was finishing his fellowship at 
Hopkins and recruited him to Moffitt,” explains William S. 
Dalton, M.D., Ph.D., former president, chief executive officer, 
and center director of the H. Lee Moffitt Cancer Center and 
Research Institute at the University of South Florida in Tampa. 
“It was one of the best hires I’ve ever done.”
At Moffitt, Sotomayor served as the scientific director 
of the center’s DeBartolo Family Personalized Medicine 
Institute, and at the national level he joined several commit-
tees, including the NCI parent committee A, where he 
helped review NCI-designated centers. The criteria for 
earning the designation include having established, collab-
orative research programs and an institutional commitment 
to, and capability for, cancer care. GW is poised to be the 
next center on the list.
“We’re going to find our own niche,” Sotomayor says. “I 
think by doing that, we’re going to have a very good chance 
down the road to get an NCI designation.”
The Future: Personalized Medicine
The final component of Sotomayor’s approach is as revolu-
tionary and forward thinking as cancer immunotherapy: 
personalized medicine.
“Personalized medicine in my view has two essential 
components,” Sotomayor explains, pointing to phenotype and 
genomic data. “You need both.” The key for the components 
is creating tissue-related and demographics-related databases, 
where doctors and researchers can determine the makeup of 
past and current cancer patients; ideally, the information can 
be used to guide more precise, individualized treatment. “We 
want to provide state-of-the-art clinical care, we want to do 
novel clinical trials, and personalized cancer care will be the 
engine speeding up these efforts,” Sotomayor says. “That’s 
where the field is moving.”
The people in his life, those who’ve observed his ascent, 
believe his success — like the success of GWCC — is guaranteed.
“[GW is] very lucky to have him as the new director,” 
Lopez says.  
BY CAROLINE TRENT-GURBUZ
Sotomayor: 
Physician,  
Scientist,  
Researcher,  
Visionary
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hen Maria Chiara Manzini, Ph.D., was a first-year 
student at the University of Pavia in Italy, she had 
her choice of careers. Ultimately, she focused on 
studying the brain and behavior, but she couldn’t 
shake one thought. “I was always struck by how, in many 
cases, psychiatric disorders are chemical imbalances, but they 
completely change your personality,” says Manzini, assistant 
professor of pharmacology and physiology at GW’s School of 
Medicine and Health Sciences. “When you have high blood 
pressure, it’s treated with a drug, and you’re reset to normal 
levels. But with psychiatric problems, it overtakes so much of 
your life. I realized how unfair and how misunderstood it was.”
That combination of compassion and curiosity has 
helped guide Manzini on a nearly decade-long journey to help 
improve the lives of children with intellectual challenges and 
autism. An award presented by the Eunice Kennedy Shriver 
National Institute of Child Health and Human Development, 
which started as a career-development grant during Manzini’s 
postdoctoral career, grew on her promise as an investigator to 
become $740,000 to be applied to her independent research 
into severe intellectual disability and autism caused by loss of 
function of the CC2D1A gene. 
Manzini’s project, titled “Intracellular signaling in the 
development of human cognitive function,” explores the func-
tion of the gene and of the mutations that cause disease by both 
using cell-based systems — analyses of neurons generated from 
animal models — and studying the behavior in mouse models to 
better understand the pathogenesis of the disease. 
Autism does not fit a simple definition, according to 
Manzini, who earned her doctorate in neurobiology and 
behavior from Columbia University. “That’s why it’s called 
autism spectrum disorder. We now know that it can have 
multiple different causes,” she says. “We also know it’s a devel-
opmental disorder and most likely starts in the fetus, but it is 
often diagnosed when a child is 2 or 3.” 
She categorizes the intellectual disabilities at the center 
of her research as severe. “An example would be someone who 
grows up to be a 30-year-old who functions at about the level 
of a 3-year-old and is able to say around three words,” she says. 
“They never adapt and continue to have the capacity of a very 
small child.
“For example, they probably don’t know what money is, 
and they might have issues with expressing themselves,” she 
explains. “With autism, it’s also issues in social interaction 
and repetitive behaviors.” One thing they all have in common 
is that they have no other physical or neurological conditions, 
and their only difficulties are in brain functions controlling 
cognition and behavior.
DETECTIVE WORK
Manzini still remembers the excitement of discovering the 
CC2D1A gene mutation in 2006 at the Boston Children’s 
Hospital lab that led to so much of her work. “We found it in 
the DNA sequence, but we didn’t know anything about what 
losing that gene did to the brain” she says. “You needed to 
generate a model to look at the brain to see if it’s normal — 
asking questions like: Does the animal model have a learning 
deficit or a social deficit? We could find the source of the 
problem in the genetics, but you can find the gene and still not 
know what that gene does. It’s truly detective work.”
She knew early on that she wanted to get beyond identi-
fying the genes, to figure out how the gene regulates multiple 
signaling mechanisms inside the cells, as well as how it 
responds to the outside. Only then can Manzini establish ways 
MAKING STRIDES
in Childhood Intellectual Disabilities 
and Autism
BY ERIC BUTTERMAN
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to modulate the gene and have a positive effect on the disease. 
“You see the neuron is not quite able to respond to stimuli from 
the outside, and we’re trying to figure out from a molecular 
point of view why there is the misinterpretation,” she explains. 
“You also want to look into whether there are applicable drugs 
available or hopefully create ones that will help restore normal 
responses in the neurons.”
Presently, Manzini is focused on behavioral tests through 
animal modeling, looking at learning capacity, social inter-
action, and whether the subject’s behaviors are repetitive. 
Examples of tests include having a mouse subject in a cage with 
a sibling and an unknown mouse and looking at how often the 
subjects choose to interact with each other. “A lot of the time the 
ones with social deficit won’t even care,” she explains. “If they 
don’t have a social deficit, they’ll tend to go to the mouse they 
don’t know because it’s someone new — they are checking out 
if they’re friend or foe.” Or, to study anxiety, researchers might 
put the mice in an open box and see how often they’re willing to 
leave the sides and go into the open space in the center.
“We’re also looking at animals with self-injury and other 
issues,” she says. “The final overarching goal is to understand 
the molecular deficits caused by loss of this gene and see if we 
can cure behavior in the animal model and extend that to other 
autism research.” The problem, explains Manzini, is that liter-
ally hundreds of genes are affected. “We have to try to figure 
out whether we can group patients based on genes with similar 
functions, or do more when it comes to understanding how the 
different genes work together.”
Manzini says her work is still in the early phase, and she is 
working to understand why these mutations cause these effects 
on brain function and development. “Specific electric signals 
when you develop a memory become stronger,” she says. “You 
can measure the strength of these electrical signals and see 
whether the cell is able to increase its strength. But, in our case, 
in our models, that doesn’t happen. … Where we’re at now, we 
have cellular deficits and some other deficits, but what we want 
to do is to get the molecular deficit. So, we go inside the cell and 
figure out what is wrong and what is the cause.”
FAMILY MATTERS
Manzini’s passion grew partly out of meeting families affected 
by autism, believing it was important to get beyond the micro-
scope in this kind of work. “We have families in genetic labs 
trying to get more information, and we have to try to help them 
make sense of this genetic disorder,” she says. “It’s also very 
helpful to see the positive [side] and the love of the parents for 
these kids — it’s been really inspiring. I recommend that even 
if you always work with DNA and just see the samples, you 
want to understand what people are going through. By under-
standing the community and seeing what effect [a disease] has 
on the quality of life, you can focus on those aspects of the 
disease, and it can inform your work.”
One family visit led Manzini and her medical team as far as 
a mountain peak at the tip of the Arabian Peninsula in Oman. 
“You go through the desert, climb a dirt road, and they were 
in a mud building on the top of a mountain,” she recalls. “They 
were really excited to see us — I believe the two brothers and 
their wives had seven children who were affected. You could 
see how driven they were to find out what had happened to 
their children and how much they wanted to help them.”
But the families go beyond offering inspiration — they’ve 
provided vital clues. “When we first identified mutations in 
CC2D1A, it was in a family who had severe cognitive deficits,” 
she says. “Then another family with the same mutation had 
intellectual disability, but also had autism. A third [who] had 
a different mutation also had both intellectual disability and 
autism.” Confusing, yes, but also challenging, says Manzini.
As Manzini trudges on, she is strongly encouraged by 
improvements in the positivity of the medical community. “In 
the past five to 10 years, we have gained a better understanding 
of what causes these disorders,” she says. “And right now there 
is a lot of focus on trying to develop therapies. It’s hard to 
believe that just five years ago there weren’t really any clinical 
trials! You want to know the difference? I was at a conference 
recently, and it’s so great to see clinicians, scientists, and phar-
maceutical companies talking about a variety of disorders and 
assessing improvements in learning. Advocacy groups should 
be very proud of the role they’ve taken.”
And it’s extra incentive for her to also see the way society 
has changed its view. “Young children are receiving early diag-
nosis and extra help at home and in school,” she says. “Therapists 
are playing a very important role. We can make their lives better 
in many ways … and I think it will only improve.”  
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BY STEVE GOLDSTEIN
When people reach the pinnacle of their profession, 
we sometimes call them rock stars. They are 
showered with adulation, and we say they’ve turned 
their talents into performance art. For surgeons, 
tasked with bridging science and art, intellect and 
dexterity, the allusion is more fact than flourish. 
BY STEVE GOLDSTEIN
PHOTOGRAPHS BY BARBARA 
MCGOWAN AND MICHAEL LEONG, 
BIOMEDICAL COMMUNICATIONS
Take J. Keith Melancon, M.D., professor of surgery and chief 
of the Division of Transplant Surgery at GW’s School of 
Medicine and Health Sciences (SMHS) and director of the new 
GW Transplant Institute at George Washington University 
Hospital (GW Hospital). Describing the charismatic and 
dapper Louisiana native as a transplant surgeon is a little bit 
like saying Mick Jagger has some stage presence. Which, in a 
way, explains why Melancon got into the business of swapping 
organs in the first place. 
Melancon’s medical baptism first came from the hindquar-
ters of a cow — more on this later — but he always envisioned 
himself as a surgeon. As a boy in Lafayette, Melancon idol-
ized Hawkeye Pierce, the wisecracking protagonist-M.D. of 
the 1970s television show “M.A.S.H.” Through his mother, a 
surgical nurse at Charity Hospital, he got a firsthand view of 
the dominion doctors held in the hospital world. 
That impression — surgeons as saviors — became 
permanently stitched on his psyche. Years later, Melancon, 
a third-year medical student researching a project on trans-
plantation, witnessed a daily miracle in the OR. “The surgeon 
took the kidney out of the ice bucket, prepared the patient, and 
connected the vessels and the kidney, which was white, pale, 
and cadaveric,” he recalls. “Suddenly, it came to life.
“The surgeons were like rock stars,” Melancon exclaims. “I 
wanted to be a rock star!”
Now a transplant surgeon, the 46-year-old father of four 
boys has earned that status, with more “firsts” on his resume 
than a van full of valedictorians. In 2009, Melancon, leading 
the charge in making transplantation more widely avail-
able to the Washington, D.C. community, headed a team 
that performed a 26-person paired kidney exchange — 13 
recipients and 13 donors. A year later, he helped set a record 
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with a 32-person kidney swap. The key in both these massive 
exchanges, says Melancon, is the altruistic donor — someone 
willing to donate one of his or her two kidneys, which can set 
off a “daisy chain,” in Melancon’s words, of matches between 
donors and patients.
At GW Hospital in late June 2015, to the tune of classic rock 
playing softly in the background, Melancon and Thomas Jarrett, 
M.D., professor and chair of  the Department of Urology at 
SMHS, led such a daisy chain: a successful three-way paired 
kidney exchange. The procedures were the first ever at GW 
Hospital, and tricky ones at that. “The unique nature of the 
exchange was the fact that all of these recipients had received 
kidney transplants many years ago and were in need of new 
transplants, but [the kidneys of] their loved ones did not match,” 
he explains. “The patients were ‘sensitized,’ meaning it’s even 
harder to find a match.”
The transplant program Melancon and colleagues are 
building at GW, however, is dedicated to utilizing all means of 
performing live donor transplants. “We were able to help these 
patients find other transplant patients in the same predicament 
of needing a better-matched donor than their loved one,” he says. 
“We always aggressively push for local paired kidney exchange, 
because it is the quickest, most convenient, most cost-effective, 
and most reliable means of transplanting the most patients.”
“It’s not just one person,” adds Muralidharan Jagadeesan, 
M.B.B.S., associate professor of medicine and chair of transplant 
medicine at SMHS, and medical director of the renal transplant 
program at GW Hospital, about the transplant team being 
created at GW. “ It’s not just a surgeon, it’s not just me; it’s the 
coordinator, the social worker, the pharmacist, the dietician, 
it’s everybody on the GW transplant team who’s going to work 
together to provide the service for you, so that you can partici-
pate on this very successful voyage of kidney transplant with us.”
With the increased incidence of precipitating illnesses 
such as hypertension and diabetes, and the fact that donations 
from deceased donors are, by necessity, limited, the GW trans-
plant team has sought to bolster live donations through paired 
exchanges using altruistic donors.
All this is made feasible by the fact that humans come 
equipped with a spare kidney to share. The bean-shaped organ, 
roughly five inches long and weighing a bit more than a bar 
of soap, performs critical cleansing functions for the body, 
filtering waste materials from blood to then pass them out as 
urine. If the kidneys are not working properly, they can cause 
havoc. When that happens, patients have to go on dialysis to 
keep their bodies running, but sooner or later their kidneys 
will need to be swapped out. The good news is, although we 
are born with a pair, we can function just fine with only one 
kidney. Despite that redundancy, demand still dwarfs supply.
Numbers underline the immediacy of the crisis. Some 26 
million Americans suffer from chronic kidney disease, and fewer 
than 400,000 of them have received kidney transplants. About 
3,000 more are added to the waiting list annually, and roughly 
4,500 of those on the transplant list die each year according to 
the National Kidney Foundation. In the United States, more 
than 100,000 people with renal failure are on the list for a 
deceased-donor kidney, typically waiting between four and five 
years. With nearly 2,000 patients in the queue, D.C.’s transplant 
waiting list is the country’s longest, says Melancon. Only one in 
four will receive a transplant. And although African-Americans 
make up only about 12 percent of the U.S. population, they 
represent 23 percent of patients on the waiting list, according to a 
report by the U.S. Department of Health and Human Services. 
Organ donation, according to Melancon and Jagadeesan, 
offers patients the best of both worlds: low cost and better 
outcomes. Dialysis — which uses machines to cleanse the 
blood — is a big and profitable business. Melancon estimates 
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A
ccording to the U.S. Department of Health and Human 
Services, 34 percent of the more than 101,000 people 
on the national waiting list for a kidney transplant are 
African-American. Overall, minorities account for 58 
percent of those on organ transplant lists, but represent just 
42 percent of those who receive transplant surgery. African-
Americans make up the largest group of minorities in need of a 
transplant, at 30 percent, but they make up less than 14 percent 
of donors. Due to the greater incidence of diabetes and high 
blood pressure among African-Americans, they are more at risk 
for organ failure. Organ types are more likely to match if they 
come from individuals of the same ethnicity.
Community education is vital in reducing the rate and 
number of ethnic minority Americans in need of organ 
and tissue transplants. It’s a big part of why, when J. Keith 
Melancon, M.D., came to Foggy Bottom in the fall of 2014 to 
serve as professor of surgery at GW’s School of Medicine and 
Health Sciences (SMHS), chief of the Division of Transplant 
Surgery, and director of the Transplant Institute at GW 
Hospital, he brought with him a ready-made community 
health organization, the National Minority Organ and Tissue 
Transplant Education Program (MOTTEP®). The partner-
ship is the realization of Melancon’s vision of increasing kidney 
donations by raising awareness. MOTTEP’s expertise in the 
community helped garner support among District of Columbia 
authorities for the new transplant center.
“MOTTEP is a grassroots community organization,” 
explains Melancon. “What it has done for GW is identify the 
best access for us to reach the people with end-stage renal 
disease.” Hospitals, he adds, traditionally don’t know where 
to go to interact with the community for health interdiction. 
“MOTTEP knows the corporate structure that’s interested in 
helping, as well as where citizens tend to congregate and are 
open to this kind of discourse about health.”
At a recent community event at a local Safeway grocery 
store, scores of D.C. residents received blood pressure tests, 
cholesterol checks, weight measurements, body mass assess-
ments, and other health tests. They were also encouraged 
ADVANCING ALTRUISM National Minority Organ and Tissue Transplant Education Program Joins GW to Raise Organ Donation Awareness 
BY STEVE GOLDSTEIN
J. Keith Melancon, M.D. (left), and Muralidharan Jagadeesan, 
M.B.B.S. (center), convene weekly transplant committee meetings 
to discuss the elements of each case, from a patient’s medical 
history to current physical and mental health status, as well as the 
availability and compatibility of a live organ donor.
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that dialysis for one patient costs $80,000 to $100,000 annu-
ally, whereas a transplant runs about $30,000. Transplant 
patients also have a longer life expectancy. 
“Right now, all the advancements in immunosup-
pression and surgical techniques have improved outcome 
significantly,” explains Jagadeesan. The availability of desen-
sitization (reducing antibodies) drugs and ABO-incompatible 
transplants — meaning the donor and recipient have different 
blood types — means a broader selection of patients can be 
transplanted successfully. 
So if transplants are better, and more patients who need a 
kidney can qualify, why can’t they get them? Simply, explains 
Jagadeesan, “it’s a demand and supply problem. The demand for 
organs is not met by the supply.”
Since arriving at GW in early 2014, Melancon, with 
supportfrom Anton Sidawy, M.D., M.P.H. ’99, Lewis B. Saltz 
Chair of Surgery, and professor of surgery at SMHS, has 
made it his mission to expand the universe of donors and thus 
increase transplantation. To help achieve this goal, Melancon 
has engineered a partnership with the Minority Organ and 
Tissue Transplant Education Program to inform the minority 
community about the facts — and fictions — of kidney donation 
(see related article below).
“What I want to concentrate on is helping people in 
the hardest-to-transplant areas,” Melancon says, “and it will 
translate into more transplants for everyone who is difficult to 
transplant. That is my strategy.”
The prospects, he adds, for making a significant improve-
ment in the D.C. community is palpable.
Speaking of palpable — how now to explain the cow?
Melancon’s skill as a surgeon and as an advocate for his 
cause seem reinforced by an uncanny perceptiveness about the 
challenges ahead. One of his oldest friends, Perry Franklin, 
a classmate at Louisiana State University, recalls their first 
meeting at a post-high school summer program for minority 
students interested in veterinary medicine or health careers.
“We became fast friends,” says Franklin, “and one day we 
were being taught how to palpate a cow’s ovaries prior to arti-
ficial insemination. Keith was in front of me, but somehow he 
slipped behind me in line, and I was next. When I reached in, 
the cow explosively ejected my hand and arm and painted me 
with [awful stuff].
“Now how did Keith know not to be next in line?” 
Franklin laughs.
Perhaps that timely line swap was Melancon’s first 
transplant.  
to sign organ donor cards. “There’s been a long-standing 
suspicion in the African-American community about trans-
plants and the medical establishment,” says Melancon. 
“MOTTEP is educating people so that they understand that 
if they donate more, there will be more transplants… . We’ve 
done numerous events with MOTTEP, and they’ve been very 
successful.”
Clive Callender, M.D., who established MOTTEP in 
1991, believes Melancon’s efforts are crucial to the organiza-
tion’s mission and success. “Keith is a tremendous transplant 
surgeon,” Callender says, “but what’s special about him is his 
real love for the community and his willingness to go into the 
community to educate and empower people. He understands 
communication, and he has charisma, which makes him effec-
tive at reaching all ethnicities.”
MOTTEP, Callender explains, has created community 
programs for building relationships and raising community 
awareness regarding organ transplant in minority populations 
in the Washington, D.C. area. MOTTEP also promotes healthy 
lifestyles to prevent kidney disease.
Callender’s strategy to educate and raise awareness about 
the need for organ and tissue donation was based on over-
coming five obstacles identified through focus groups:
•  Lack of community awareness about renal disease  
and transplantation
•  Conflicting religious beliefs
•  Distrust of the medical community
•  Fear that signing an organ donor card meant medical 
personnel would not work as hard to save them 
•  Belief that their organs would go only to whites
“We have always focused on outcomes,” says Callender, a 
clinical professor of surgery at Howard University Hospital, 
where he began a local MOTTEP in 1978 with a $500 grant 
from the D.C. government to investigate low donor rates 
among minorities. “Of course, we wanted attitudes toward 
donation to change. But the important thing was to change 
behavior, and we have seen donations from blacks more than 
double since we started.”
MOTTEP joined with GW Hospital in its application to 
initiate a kidney and transplant program, and a certificate of 
need was granted in February 2014. A contract with MOTTEP 
was signed that same year and runs through 2017. MOTTEP’s 
presence at GW includes program director Patrice Miles, an 
administrator, and a regional coordinator.
“When I started MOTTEP, many people told me one 
person couldn’t change the donation equation for minorities,” 
says Callender, who, in New York City’s Harlem neighborhood, 
contracted tuberculosis at age 15 and was hospitalized for more 
than a year and a half. “My own adversity — and telling me it 
couldn’t be done — inspired me to do what seemed impossible.”  
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I n the epidemic of kidney disease, the number of people in need far outweighs those donating. Washington, D.C., more than any 
other city in the United States, has been 
at the center of this off-balance issue. 
The Ronald and Joy Paul Foundation, 
with a $2.5 million gift, is establishing the 
GW/Ron and Joy Paul Kidney Center to 
address the urgent need for community 
awareness of kidney diagnosis, treatment, 
and donation.
“Joy and I felt very strongly that if 
we could better educate the commu-
nity, then we could hopefully reduce 
the amount of kidney failure,” says Ron 
Paul, chair and CEO of Eagle Bancorp 
and Eagle Bank. “Should somebody be 
in end-stage renal failure, we want to be 
able to educate them on transplantation. 
It’s all about awareness and education. 
That’s what we’re going to be promoting 
through this center.”
For Paul, the gift strikes a personal 
note. In the 1980s, he was diagnosed 
with glomerulosclerosis, a kidney disease 
that can eventually end in kidney failure. 
“It came out of nowhere,” he says. “I 
didn’t have any pre-existing conditions, 
no diabetes, no high blood pressure, no 
issues at all other than I found out I had 
kidney failure.” Eight years later, Paul 
faced a decision of a lifetime of dialysis 
or a kidney transplant. He chose a trans-
plant, and his brother, Steven, provided 
the needed organ. The donated kidney 
lasted far beyond its typical lifespan, 
but in 2008, Paul learned he would need 
AIMING TO 
EDUCATE:
The GW/Ron  
and Joy Paul  
Kidney Center
another transplant. Again, he received 
a donation, this time from his longtime 
friend and chief financial officer of his 
company, Kathy McCallum.
“When I had my first transplant in 
1990, I had two very young children, I 
was starting a business, we had very little 
means to be able to support ourselves,” 
Paul says. “So, going from being pretty 
sick to being energetic and able to run a 
real estate company and be chairman of a 
bank, it’s a great feeling. But most impor-
tantly, now it’s a time to help others.”
Organs from live donors, such as 
Steven Paul and McCallum, are ideal; 
they shorten or completely eliminate a 
patient’s need to be placed on a waiting 
list or on dialysis, and the short- and 
long-term survival rates tend to be better 
than those from deceased donors. With 
outreach from the GW/Ron and Joy Paul 
Kidney Center, the Pauls are hoping 
to tip the balance of kidney supply and 
demand, a move that could potentially 
save the lives of Washington, D.C. 
residents.
That mission of giving back to the 
community is one to which Paul ascribes 
on a daily basis. Hanging in his office and 
at his home is a saying from Winston 
Churchill: We make a living by what we 
get, but we make a life by what we give.
“That’s what we’ve tried to teach to 
our children and family, and tried to live 
by,” he says. “It’s pretty powerful if you 
can get your arms around it.”  
BY CAROLINE TRENT-GURBUZ
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Rao Rises to Department Chair
Raj Rao, M.D., a nationally recognized authority in spinal 
biomechanics, injuries, and fusion, is expanding his expertise; 
as the new chair of the Department of Orthopedic Surgery at 
George Washington Hospital (GW Hospital) and GW’s School 
of Medicine and Health Sciences, he will position the depart-
ment for clinical and research growth.
“GW Hospital is pleased to have Dr. Rao join our 
comprehensive team as the new chair of the Department of 
Orthopedic Surgery,” said Barry Wolfman, M.S. ’84, CEO of 
GW Hospital. “Dr. Rao’s vital orthopedic research, his commit-
ment to his patients and staff, and his dedication to engaging 
with the communities he serves will help us continue GW’s 
legacy of progressive leadership. The advanced care that 
our established orthopedic team already provides will only 
benefit from his leadership and engagement.”
Rao comes to GW from the Medical College of 
Wisconsin, where he served as vice chair in the Department 
of Orthopedic Surgery and professor of orthopedic surgery 
and of neurosurgery. In 2014, Rao was appointed as chair of 
the FDA Advisory Panel on Orthopaedic and Rehabilitation 
Devices; there, he leads the panel in reviewing the safety 
and efficacy of orthopedic and spine-related devices for 
marketing in the United States. He was the recipient of the 
David Selby Award of the North American Spine Society 
in 2014.  
FACULTY NEWS
Pattern Potential
In the battle against HIV/AIDS, new 
research co-authored by Douglas F. 
Nixon, M.D., Ph.D., Walter G. Ross 
Professor and chair of the Department 
of Microbiology, Immunology, and 
Tropical Medicine at GW’s School of 
Medicine and Health Sciences (SMHS), 
points to immune responses as a 
potential deciding factor in infection. 
According to Nixon’s findings, some 
individuals who have been exposed to 
HIV-1, but who remain uninfected, have 
a different pattern of virus-specific 
immune responses from those who 
became infected with the retrovirus.
“Research has shown that T-cell 
responses can be observed in virally 
exposed but uninfected persons,” said 
Nixon. “The question that has remained 
unanswered is whether or not these 
T-cell responses could be protecting 
people from acquiring systemic HIV 
infection. What we found was … a corre-
lation between future infection risk and 
a measurable immune response.”
Nixon and colleagues from the 
University of California at San Francisco; 
the University of Sao Paulo in Brazil; 
and the Gladstone Institutes reviewed 
data from the Pre-exposure Prophylaxis 
Initiative (iPrEx) trial, the first random-
ized controlled trial of pre-exposure 
chemoprophylaxis (PrEP) in humans. 
Remaining specimens from the trial 
were used to test for naturally acquired 
or induced immunity to HIV-1 infec-
tion. The team discovered that those 
who became infected typically lacked 
responses to two HIV-1 proteins. The 
findings, published in the Proceedings 
of the National Academy of Sciences, 
suggest that such immune responses 
may play a role in blocking systemic 
infection after exposure to the virus.  
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The Wright Stuff
Karen Wright, Ph.D., PA-C, was selected to serve as the 
interim chair and program director of the Department of 
Physician Assistant Studies at the GW School of Medicine 
and Health Sciences.
Wright brings more than 28 years of experience as a 
physician assistant (PA) to the position, and much of her 
career has been dedicated to the education and develop-
ment of future PAs. She has been a member of the GW 
faculty since 2008 and has served in a leadership role as 
the director of research, program evaluation, and admis-
sions. Wright also served as the associate program director 
during the reaccreditation process. GW’s PA program is one 
of the top-ranked PA programs within the United States and 
recently earned reaccreditation for a full seven-year term.  
Doctor–Editor
Gaetano 
Lotrecchiano, 
Ed.D., Ph.D., 
assistant 
professor 
of clinical 
research and 
leadership 
and of pedi-
atrics at GW’s School of Medicine and 
Health Sciences, is branching out to add 
“associate editor” to his list of titles. On 
July 1, 2015, Lotrecchiano assumed his 
new role at the Journal of Collaborative 
Healthcare and Translational Medicine 
(JCHTM), formerly published as the 
Journal of Translational Medicine and 
Epidemiology. 
The international peer-reviewed 
journal is dedicated to the advancement 
of research, science, editorial, review, 
and practical applications in the areas 
of translational health care and medi-
cine. In addition to “bench to bedside to 
market” processes, the JCHTM strives 
to highlight the collaborative aspects 
of translational science through the 
contributions of team science research, 
social and behavioral science, economic 
and technological inquiry, and the 
experience of health and biomedical 
professions involved in translational 
health and medical sciences.
“I am honored and humbled by 
the opportunity to serve in this role 
within the JCHTM,” Lotrecchiano said. 
“Contributing to science is very impor-
tant to me as a professor and a scholar. 
My goal is to lead the JCHTM to offer 
commentary, research, and communi-
cations to an audience of medical and 
health care researchers, practitioners, 
and policy-makers through the presen-
tation of relevant and high-quality 
scholarship.”  
Akman Joins PACHA
Jeffrey S. Akman, M.D. ’81, RESD ’85, 
vice president for health affairs at 
GW, Walter A. Bloedorn Professor of 
Administrative Medicine, and dean of 
GW’s School of Medicine and Health 
Sciences, was sworn in as a new member 
of the Presidential Advisory Council on 
HIV/AIDS (PACHA) on May 21, 2015. 
As part of PACHA, Akman, who has 
treated patients living with HIV since the 
beginning of the epidemic, will work with 
local and national community leaders, as 
well as leaders from science, medicine, 
public health, business, and philan-
thropic organizations to provide advice, 
information, and recommendations 
on HIV-related issues and policies to 
the Department of Health and Human 
Services and the White House.
“I am thrilled to be a part of this 
important group,” said Akman. “As 
a psychiatric physician, I understand 
the importance of sound national and 
federal HIV/AIDS policy and its implica-
tions for the delivery of care and overall 
well-being for many patients with HIV/
AIDS and those at high risk for the 
disease. I look forward to working with 
my colleagues on this council as we help 
guide our nation’s top leaders in making 
informed decisions related to HIV/AIDS.”
For many years, Akman has been 
advising physicians, research institutes, 
and medical organizations on the need 
for mental health and substance use 
care to be included when treating HIV 
patients. In his role as an advisor, he 
served as the principal investigator for 
a NIH grant to train health care profes-
sionals in the medical and mental health 
aspects of HIV/AIDS.
He has provided leadership and 
advisement for many prestigious HIV/
AIDS-related initiatives, including the 
American Psychiatric Association’s first 
commission on AIDS. He also served on 
the Mayor’s Commission on HIV/AIDS 
and chaired the commission’s Treatment 
on Demand Committee.  
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Nitric Oxide 1, Acne 0
Chalk up another entry on the list 
of medical ailments that nitric oxide 
treats. The cellular signaling molecule 
is already associated with the treat-
ment of conditions such as pulmonary 
hypertension and acute respiratory 
distress syndrome, and it plays a key 
role in the function of medication 
for erectile dysfunction. Now, GW 
researcher and dermatologist Adam 
Friedman, M.D., has discovered that 
the release of nitric oxide over time 
may effectively treat and prevent 
acne. The research, published in the 
Journal of Investigative Dermatology, 
suggests that nitric oxide nanoparti-
cles are effective at killing the bacteria 
associated with acne. More impor-
tantly, the nanoparticle treatment 
inhibits the damaging inflammation 
that results in the large, painful lesions 
associated with inflammatory acne.
“Our understanding of acne has 
changed dramatically in the last 15 
to 20 years,” said Friedman, asso-
ciate professor of dermatology at 
GW’s School of Medicine and Health 
Sciences and co-author of the study. 
“Inflammation is really the driving force 
behind all types of acne.”
The study focused on a recently 
identified pathway known as an 
inflammasome, responsible for 
the activation of the inflammatory 
Margaret M. Plack, Ed.D., DPT, PT, 
has been named interim chair of the 
Department of Clinical Research and 
Leadership (CRL) at GW’s School of 
Medicine and Health Sciences. In her 
new position, Plack will oversee and 
provide leadership support for the 
department’s 12 programs.
With more than 25 years of experi-
ence in both academic and clinical 
In the Name of  
Student Support
Katherine Chretien, M.D., associate 
professor of medicine and new 
assistant dean for student affairs for 
GW’s School of Medicine and Health 
Sciences, is bolstering support for 
students navigating their medical 
education and career prospects.
As a member of the dean’s execu-
tive leadership team, Chretien, in her 
new role, will participate in the devel-
opment and operation of an accredited 
undergraduate medical education 
program. She also will develop a career 
counseling program and a system 
for access to health services; prepare 
the Medical Student Performance 
Evaluation for senior medical students; 
and provide leadership in the devel-
opment of programs and policies 
designed to foster the academic, 
personal, and career success of a 
diverse student body.
Additionally, Chretien will partici-
pate in the student admissions process, 
including interviewing and reviewing 
files of potential students, as well as 
assisting with the planning and imple-
mentation of strategies leading to 
successful accreditation of the under-
graduate education program.  
process in acne. Friedman and 
colleagues from Albert Einstein 
College of Medicine and the 
University of California at Los Angeles 
determined that nitric oxide served 
as an effective means of killing the 
bacterium that causes acne without 
using an antibiotic. They also found 
that its use inhibits the inflammasome 
pathways central to the formation of a 
pimple before it is even visible.
“By killing the bacterium and 
blocking multiple components of the 
inflammasome,” explained Friedman, 
“this approach may lead to better treat-
ment options for acne sufferers, and 
possibly treatments for other inflamma-
tory skin conditions.”  
practice, Plack, a professor of physical 
therapy and health care sciences, 
brings outstanding credentials to the 
stewardship of CRL. A longtime leader 
at SMHS, she has served as the director 
of the Physical Therapy program, chair 
of the Department of Health Care 
Sciences, and interim senior associate 
dean for health sciences since joining 
the faculty in 2004.  
Margaret Plack Named CRL Interim Chair
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The “Kick and Kill” Strategy
GenerationCURE, a group of young 
professionals dedicated to supporting 
the cure-focused research of the 
American Foundation for AIDS 
Research (amfAR), recently awarded its 
inaugural $180,000 research grant to 
Brad Jones, Ph.D., assistant professor 
in the Department of Microbiology, 
Immunology, and Tropical Medicine’s 
Research Center for the Cure and 
Eradication of HIV in at GW’s School of 
Medicine and Health Sciences. Jones is 
employing an innovative approach to 
HIV treatment.
“It’s a terrific honor to have our 
work recognized by generationCURE, 
and we will be working especially 
hard to deliver impactful results that 
are worthy of the effort they put into 
this unique fundraising initiative,” said 
Jones. “If successful, our work will set 
the stage for clinical testing of novel, 
potentially curative HIV therapeutics.”
Jones and his colleagues are 
exploring whether a novel combina-
tion therapy can eradicate the latent 
reservoirs of HIV that present a major 
barrier to finding a cure. Although 
antiretroviral therapy can reduce active 
HIV to undetectable levels in the blood, 
it cannot reach dormant HIV in cells, 
which can reactivate and replicate 
at any time. The team will employ a 
strategy known as “kick and kill” to 
attack this reservoir. Many researchers 
using this approach have been chal-
lenged by their patients’ immune 
systems’ inability to kill the cells 
infected with the reactivated virus.
Jones hopes to overcome this 
challenge by using a drug that 
increases the activity of a protein 
known as TLR2 (a TLR2 agonist). They 
have previously shown that the TLR2 
agonist can reactivate — or “kick” — the 
latent HIV in infected cells, while 
simultaneously boosting the ability of 
a patient’s own cytotoxic T-cells to kill 
those infected cells.  
The “Low-T” and 
Depression Link
Researchers at GW, led by Michael S. 
Irwig, M.D., found that men referred 
for tertiary care for borderline testos-
terone levels had much higher rates of 
depression and depressive symptoms 
than those of the general population.
“In an era where more and more 
men are being tested for ‘Low T’ — or 
lower levels of testosterone — there is 
very little data about the men who have 
borderline low testosterone levels,” said 
Irwig, associate professor of medicine 
and director of the Center for Andrology 
at GW’s School of Medicine and Health 
Sciences. “We felt it important to explore 
the mental health of this population.”
The research, slated to be 
published online in the Journal of 
Sexual Medicine, focused on 200 adult 
men, aged 20–77 years, who were 
referred for borderline total testos-
terone levels between 200 and 350 
ng/dL. Depression and/or depressive 
symptoms were present in 56 percent of 
the subjects. Furthermore, one-quarter 
of the men in the study were taking 
antidepressants and had high rates 
of obesity and low rates of physical 
activity. The most common symptoms 
were erectile dysfunction, decreased 
libido, fewer morning erections, low 
energy, and sleep disturbances.
Although more research is needed 
in this area of study, the researchers 
concluded that clinicians should 
consider screening for depression and 
depressive symptoms, overweight, and 
unhealthy lifestyle factors in men who 
are referred for tertiary care for poten-
tial hypogonadism.  
Listening and Learning
Collaboration between health care 
professionals, researchers, and institu-
tions is quickly becoming the name 
of the game; to that end, Ashkan 
Monfared, M.D., associate professor 
of surgery and neurosurgery at the 
GW School of Medicine and Health 
Sciences, and his colleagues from 
Global ENT Outreach, El Centro de 
los Sentidos, and Clinica de Marly 
hosted the first Advanced Otology 
and Temporal Bone Course in Bogota, 
Colombia. The two-day, hands-on 
course provided instruction for complex 
otologic surgeries that can cause poten-
tially devastating morbidity in patients.
“It was a great opportunity to 
work with these medical trainees in 
Colombia and assist in sharpening their 
surgical skills so they can significantly 
improve outcomes for patients with 
otologic disorders,” said Monfared, 
who served as a course faculty member 
with support from the Ruth Uppercu 
Paul Fund for Hearing Health and 
Rehabilitation. “The response from the 
group was overwhelmingly positive, and 
they asked for additional opportunities 
for training. It’s our goal to offer this 
course twice per year and to extend the 
hands-on section by an extra half day.”
In addition to his work with the 
course, Monfared helped develop the 
mission for a charitable hearing health 
organization founded by one of the 
course leaders, Martin Fernandez, M.D. 
Monfared will coordinate the efforts 
between GW and the organization — the 
first of its kind in Colombia — and serve 
on its board of directors.  
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Edward Seto to Spearhead Basic 
Sciences at GW Cancer Center
The newly established GW Cancer Center, with director 
Eduardo Sotomayor, M.D., at the helm, has tapped Edward 
Seto, Ph.D., as the associate director for basic sciences. 
Seto, an internationally recognized scientist and leader in 
cancer epigenetics, will spearhead the center’s ongoing 
development, implementation, and evaluation of basic 
science-related programs and initiatives. 
“I am thrilled that a basic scientist and a leader of the 
stature of Ed Seto has joined the GW Cancer Center team. 
He is the kind of scientist that every major cancer center 
would love to have. We are very pleased that among all the 
cancer centers that he was enticed to join, Ed has chosen the 
GW Cancer Center to continue with his extremely productive 
scientific career,” said Sotomayor, who also holds the posi-
tion of professor of medicine at GW’s School of Medicine 
and Health Sciences (SMHS). “Ed and I, along with the senior 
leaders of GW, the GW Medical Faculty Associates, and 
GW Hospital, shared the same vision that strength in basic 
science is fundamental for the building of an innovative 
cancer research enterprise.”
Seto’s additional responsibilities include collaborating 
with other associate directors of cancer centers — particularly 
those specializing in clinical investigation, population science, 
administration, and education, among others — to integrate all 
programs, and identifying areas that could become potential 
scientific programs and part of the National Cancer Institute 
designation grant application. Seto will also serve as professor 
of biochemistry and molecular medicine at SMHS.  
Save the Date!
See you back at Ross Hall soon!
We look forward to celebrating  
the M.D. Program classes of
1966, 1976, 1981, 1986,  
1991, 1996, and 2006
Get involved now by contacting 
smhsalumni@gwu.edu or (202) 994–7511
ALUMNI WEEKEND 2016
September 30 thru October 2
Leadership in Research
Award-winning neuroscientist and published researcher 
Robert H. Miller, Ph.D., attributes much of his success to 
honing his approach to science.
Becoming a scientist “is asking important questions 
that are practical and designing experiments that give you 
unambiguous answers,” said Miller, senior associate dean for 
research and professor of anatomy and regenerative biology 
at the GW School of Medicine and Health Sciences (SMHS). 
“If you can do that, you can do science.” 
Miller’s words came as part of his formal installation in 
May 2015 as the Vivian Gill Distinguished Research Professor. 
The professorship was created in 1967 by a gift from Thomas 
H. Gill in memory of his wife, Vivian. Miller joined past 
distinguished Gill professors David Reiss, former professor 
of psychiatry and behavioral sciences, of medicine, and 
of psychology at SMHS; and Steven R. Patierno, adjunct 
professor of pharmacology and physiology at SMHS. 
Miller joined the SMHS faculty in June 2014, having 
previously served as the vice president for research at Case 
Western Reserve University.  
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W
hen it comes to higher education in the United 
States, cost can be a serious impediment for 
ambitious students, especially those seeking 
to carve out careers in medicine and the health 
sciences, the Association of American Medical Colleges 
reports. Compounding increasing costs are additional years 
of residencies and internships, at times compelling soon-to-be 
clinicians to make specialty decisions based on finances, rather 
than desires. In an effort to ease those pecuniary burdens, 
GW’s School of Medicine and Health Sciences (SMHS) has 
established, and continues to explore, new avenues of financial 
support.
“It is vital that our students, tomorrow’s leaders in medi-
cine and the health sciences, are not limited when it comes to 
serving their communities,” says Jeffrey S. Akman, M.D. ’81, 
RESD ’85, vice president for health affairs at GW, Walter A. 
Bloedorn Professor of Administrative Medicine, and dean of 
SMHS. “That is why we continue to prioritize current-use and 
endowed scholarships, as well as additional philanthropic aid.”
ADOPT-A-DOC
Daegu, South Korea, native Jiyong Lee, M.D. ’15, didn’t expect 
to receive a scholarship before attending SMHS; as an interna-
tional student, he wasn’t even eligible for federal loans. His first 
year at GW, however, he and Allison Hoff, M.D. ’15, became 
the first recipients of the then nascent scholarship program 
“Adopt-a-Doc.”
Adopt-a-Doc began with a gift from Russell Libby, 
M.D. ’79, assistant clinical professor of pediatrics at SMHS, 
who donated funds in memory of his mother, Leona Libby 
Feldman. The idea of the gift — a minimum of $20,000 to be 
spread equally over a four-year period — was to make both 
an immediate and lasting impact on students’ debt burden, 
including on the accumulation of compounding interest, while 
ensuring donors knew the student who was benefiting. “I feel 
good knowing that the contribution has a name and a face 
and is [meant for] someone for whom I can potentially act as a 
mentor,” Libby said at the time of his donation.
Sandra Caskie, M.D. ’82, also pledged a gift in memory of 
a loved one: her former classmate and close friend, Henrietta 
Leonard, M.D. ’82, RESD ’85, a Rhode Island–based psychia-
trist who died in 2007. Caskie’s gift went to Lee, Libby’s to 
Hoff, who is now a resident at the University of Maryland 
Medical Center. 
For Lee, the gift was invaluable, allowing him to focus 
on primary care medicine, a field typically less lucrative than 
others. “The second I got a call from Dr. Caskie, I had less 
of a burden than other people, and I could pursue a career in 
primary care, which I really wanted to do,” says Lee, a resident 
at Dartmouth-Hitchcock Medical Center in New Hampshire. 
“Sometimes other students don’t have that opportunity, and 
they try to divert their paths to the more specialized fields for 
a better income. This scholarship provided me room finan-
cially, and Dr. Caskie encouraged me to pursue my career in 
primary care.”
Since its inception, Adopt-a-Doc has grown to include 
nearly two dozen scholarships. One contributor, Tom Flynn, 
M.D. ’86, is supporting five medical students, and the SMHS 
and
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Class of ’87 banded together to provide support to a member of 
the next generation of physicians. 
To learn more about becoming involved in the program, 
contact Sumana Chatterjee, director of development, at 
schatter@gwu.edu or (202) 994-6724, or visit smhs.gwu.edu/
give/power-of-giving/adopt-a-doc-scholarship.
WHITE COAT INITIATIVE
The white coat, though simple in design, is an iconic symbol 
for those in health care; when they don their coats for the first 
time — a passage treated with ceremony and respect — medical 
and health sciences students are reminded of their commitment 
to, and passion for, healing. Putting on the coat also signifies the 
start of a career and the responsibility and trust that decision 
entails.
In recognition of that milestone, the White Coat Initiative, 
which started in 2001, allows SMHS alumni to forge relation-
ships with students entering the field, acting as a welcome to 
the professional community. For medical students, alumni’s 
financial support provides for white coats, supplies used during 
Community Service Day, and educational technology and soft-
ware, in addition to other activities. More recently, in the fall 
of 2014, the White Coat Initiative helped to provide incoming 
medical students with iPads and iPad minis, part of an SMHS 
transition toward a paperless curriculum and more accessible 
program materials. The White Coat Initiative was extended 
two years ago to physician assistant (PA) students, who receive 
their long white coats at a pre-graduation ceremony.
“It is truly reassuring that I am following in the footsteps 
of qualified, driven, well-educated GW alumni,” says Elizabeth 
Prevou, PA-C ’15, M.P.H. ’15. “To have them as part of my White 
Coat Ceremony, and to wear a white coat gifted by one of them, 
is a reminder for me to keep perspective, continue persevering, 
and honor my chosen profession.”
For more information on the M.D. White Coat Initiative, 
please contact Lisa Harter at lwharter@gwu.edu.
For more information on the PA White Coat Initiative, 
as well as for information on options for physical therapy and 
other health sciences students, please contact Sarah Klein at 
smklein@gwu.edu.
ENDOWED SCHOLARSHIPS
Each year, SMHS provides more than $5 million in support; 
close to 75 percent of students receive funds. Of those, around 
half receive private philanthropic aid. Endowed scholar-
ships — which total close to 80 — offer considerable funding 
opportunities for students. Some provide general support for 
students in medicine and the health sciences, whereas others 
are more tailored to the interests of the donors. The Ella F. 
Andrews, the Anna Bartsch, and the Hazel Mae Bayne, M.A. 
’30, B.A. ’25, Scholarship Funds, for example, provide assistance 
The George Washington University School of Medicine and 
Health Sciences (SMHS) held a special reception in Sag Harbor, 
New York to benefit SMHS organizations, The Research Center 
for the Eradication of HIV and The Rodham Institute for Health 
Care Provider Education to Eliminate Disparities, at the home of 
John D. Evans and Steve Wozencraft on Aug. 29. 
The event, principally sponsored by the John D. Evans 
Foundation, as well as Sisley Paris, Royal Asscher, and the 
Cyrus Katzen Foundation, featured a welcome from host John 
Evans followed by remarks from Jeffrey S. Akman, M.D. ’81, 
RESD ’85, vice president for health affairs, Walter A. Bloedorn 
Professor of Administrative Medicine, and dean at SMHS, as 
well as Douglas F. Nixon, M.D., Ph.D., Ross Professor of Basic 
Science Research and chair, Department of Microbiology, 
Immunology, and Tropical Medicine at SMHS; and Jehan 
El-Bayoumi, M.D., RESD ’88, founding director, The Rodham 
Institute and professor of medicine at SMHS.
to female students; the Henry and Mary Amster and Louise 
Greenburg Amster Scholarship Endowment in Medicine, 
on the other hand, awards funding to those with an interest, 
knowledge, and commitment to the Jewish community. 
Additional scholarships target students specializing in specific 
fields, such as radiology or health care delivery, and the Eugene 
B. Casey Scholarship Fund provides four years of full tuition, 
room, and board.
“Here at GW, we know the bedrock of our mission is 
educating and training the next generation of physicians and 
healers,” says Dennis Narango, M.A., CFRE, associate vice 
president and associate dean at SMHS. “The bottom line is 
that we need a robust scholarship program in order to attract 
the best and the brightest.”  
 GWMEDICINEHEALTH.COM 31

I
n the coastal town of Santa Maria, California, about three 
hours northwest of Los Angeles, the Shepard family —
Dennis, Franziska, Daniel, and Nancy — regularly gathered 
at the dinner table to discuss the practice and business of 
medicine. It was a tradition that Dennis Shepard, M.D. ’63, 
traces back to his wife’s childhood in Vienna, Austria.
“She was raised in the hotel and restaurant industry, and 
they were all wonderful cooks, unbelievably good,” Dennis 
recalls. “They cooked a lot and would eat a lot, and … everyone 
sat around and talked. This passed onto me.”
Although he hesitates to use the term “push,” Dennis 
believes that the dinner table conversations steered his children 
toward the service industry; Nancy became a lawyer, and Daniel, 
M.D. ’96, M.P.H. ’96, followed his father’s lead into medicine. 
“I feel like I have an unusual perspective because I have an 
institutional view of medicine that goes back almost 50 years 
now,” Daniel says. “We were talking about everything from 
diagnostic techniques to governmental policy and billing prac-
tices, at a very early age. That was dinner table conversation.”
Both Dennis and Daniel — a unique pair of father-son GW 
School of Medicine and Health Sciences (SMHS) alumni — 
specialized in ophthalmology, though as Daniel explains, their 
drives for medicine were different. “My father, in addition to 
providing quality medical care to the patients in the commu-
nity, was looking for a type of notoriety,” Daniel explains. “He 
wanted to make a splash. I’ve had a little more internal moti-
vation. I have been, for want of a better term, an adrenaline 
junkie for all of my life.”
It’s an assessment that Dennis agrees with. The elder 
Shepard’s path into medicine started in childhood, when his 
mother suggested he go into a profession where he could “wear 
a white coat,” rather than follow the family business of farming. 
Dennis eventually enlisted in the military and served as a 
combat medic during the Korean War. He was also stationed in 
Vietnam and Japan, and his career led him to running MASH 
units and building walk-in clinics. When it came to applying 
to medical school, however, Dennis hit a bump. He applied to 
fewer medical schools than his peers, and an early struggle with 
math affected his GPA. Dennis’s mother called Howard Stern, 
the Shepard family doctor who had ties to GW, who “put in a 
good word for me,” Dennis says.
“I owe a lot to GW because they accepted me when 
nobody else would even give me an interview,” he explains. “It 
made a total difference, 100 percent difference, in my life. It 
permitted me to be a doctor.”
Dennis became a prominent surgeon and ophthalmolo-
gist who pioneered development in intraocular lenses and 
refractive surgery. In 1967, he founded the Santa Maria-based 
Shepard Eye Center, one of the largest private eye clinics in the 
world. A little over a decade ago, the Shepard Eye Center and 
Kendall Optometry merged and opened a second facility, the 
Kendall-Shepard Eye Center, in Lompoc, California. Dennis 
has garnered awards, such as the GW Alumni Service Award 
in 2001, and held multiple leadership positions. In short, he has 
made a splash.
For Daniel, the family business made for a natural transi-
tion. He started as a work-up technician at the Shepard Eye 
Center, and by age 14, he was passing instruments to his father in 
the operating room. He earned his EMT certificate before even 
earning a high school diploma, and he put together a first-aid 
crew in college. At GW, he became one of the few in his class to 
earn his Master of Public Health degree with his M.D. degree.
“The big drives have been one, kind of the adrenaline 
junkie,” he says, “and two, whatever I could do to distinguish 
myself from the crowd.”
Daniel toyed with the idea of pursuing pulmonary critical 
care before committing to ophthalmology, specifically retinal 
surgery. Retina, he explains, has that adrenaline element. 
“Retinal detachment, neovascular glaucoma, endophthalmitis, 
penetrating eye trauma and foreign bodies; these are the baili-
wick of the retina surgeon, and these demand an availability and 
willingness from the doctor to deal with them at any hour and 
for as long as it takes to resolve the issue,” he says. “The sense 
of precarious urgency, and the need that I fill by being here to 
provide such care in unpredictable situations, creates a satisfying 
adrenaline rush whenever such a case comes through my door.” 
Even though he and his father are in ophthalmology, he 
adds, they’re not in competition. “There were some very inter-
esting discussions when I could bring new information to the 
table because of my interest in retina, beyond what [my dad] 
had been doing,” Daniel says. “We had a lot of fun doing that.”
With the Shepards firmly established in the medical 
world, they recently decided to give back to the institution 
they credit with their initiation into general medicine. “We’ve 
got a long-term relationship with the university,” says Daniel, 
who now holds an active faculty appointment and a visiting 
lecturer role with the Department of Ophthalmology at 
SMHS. “We found ourselves in a position where we had the 
opportunity to give back.”
And so, with help from Franziska and her well-developed 
business acumen, the Shepard Professorship gift was created. 
Although the gift is still in an “incubation process,” Daniel 
explains, it will go toward the ophthalmology department. “We 
are looking forward to seeing what the medical school and the 
department are going to do with these resources,” Daniel says, 
adding that he cherishes the time he spent at GW.
Dennis echoes his son’s sentiments: “I owe everything to 
GW, and that’s where my heart of the gift comes from.”  
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of being a doctor for a professional sports 
team: You do not talk about the team. To 
be more precise, you do not talk about 
the athletes you treat on the team. The 
wrong word about a player’s health could 
hurt far more than any sprain, strain, or 
break. This is something Sanjay Menon, 
M.D. ’06, learned quickly as he began his 
career in sports medicine.
“Athletes are very sensitive about 
how their stories and interactions are 
portrayed ... there’s suspicion about team 
doctors,” says the 36-year-old son of 
Indian immigrants. Based at Suncoast 
Medical Clinic in St. Petersburg, Florida, 
Menon is the team physician for the 
National Football League’s Tampa Bay 
Buccaneers and an orthopedic consul-
tant to Major League Baseball’s Tampa 
Bay Rays and the North American 
Soccer League’s Tampa Bay Rowdies. “I 
want any athlete I work with to know I 
work for them and not anybody else.”
As a cautionary tale, he cited the 
example of a well-known sports medi-
cine surgeon who was incompletely 
quoted about a surgery performed on a 
star college quarterback. The player’s 
NFL draft value plummeted and the 
player never forgave his doctor.
“If athletes know I have their best 
interests in mind professionally, they will 
be confident that I’m watching out for 
them medically, too,” Menon explains. 
In the high-stakes world of professional 
sports, being a skilled physician, like 
being a gifted athlete, is not enough.
Though he’s the son of a successful 
orthopedic hand surgeon who designed 
the modern-day wrist replacement, 
Menon initially tried a different 
career tack. A music and humanities 
major at the University of Southern 
California, Menon sang in a rock band 
and worked as a trainee talent agent 
for the Endeavor agency, headed by Ari 
Emanuel, who was immortalized in the 
fictional TV series “Entourage.” “One 
of the greatest skills you learn in that 
business is communication,” explains 
Menon. “Physicians are often faulted 
for not communicating well.”
Ultimately, medicine lured him 
back, and Menon enrolled in a post-
baccalaureate, premedical program at 
Scripps College in Claremont, California, 
where his high achievement ensured an 
interview at GW’s School of Medicine 
and Health Sciences (SMHS). That 
brought him east to Foggy Bottom and 
a literal love affair at SMHS. He met his 
wife, Amy Strickland, M.D. ’06, at med 
school, and before long their classmates 
made up nearly a third of their wedding 
guest list. Strickland is now the gastro-
enterologist for the Tampa Bay Rays, so 
whether it’s your bones or your belly that 
is aching, the Strickland-Menon family 
has you covered, they joke.
“I’ve always felt I was extremely 
well prepared by the teachers at SMHS,” 
Menon says with pride. “That helped 
me get into a good residency program 
at Los Angeles County Harbor–UCLA 
Medical Center.” The springboard 
into sports medicine was a prestigious 
one-year orthopedic fellowship with the 
legendary James Andrews, M.D., one of 
the most innovative sports surgeons in 
the world. Andrews mentors dozens of 
jock docs, including Menon.
Menon’s 2011–12 fellowship took 
him to the Andrews Institute in Gulf 
Breeze, Florida, which features a high-
level sports fitness facility where many 
elite athletes rehab or train. He got 
his first college exposure during that 
period as a team physician for Auburn 
University. Studying at Andrews put 
Menon “on the radar” with pro teams, 
as did working with elite high school 
football teams and having a connection 
with a former Andrews fellow working 
with the Tampa Bay Rays.
“So by taking care of athletes and 
being available, [you encourage] people 
[to] think of you when positions open,” 
says Menon.
Menon is busy on and off the playing 
field, regularly seeing patients at the 
Suncoast clinic. “When it comes to an 
injury, you treat everyone the same,” he 
explains. “One of my mentors would say, 
‘Don’t get fancy.’ With athletes, however, 
the timeline [for repair and recovery] 
may get compressed. For an athlete there 
may be less of a role for conservative 
care, depending on the injury and the 
remaining schedule.”
Sports medicine requires Menon to 
stay up to date with innovative thera-
pies, particularly the use of biologics 
such as stem cells and PRP (platelet-
rich plasma) — treatments that can 
speed healing. Injury types vary with 
each sport, however. Football players 
suffer more acute injuries, such as liga-
ment tears and dislocations, whereas 
baseball produces more chronic overuse 
injuries from early specialization in a 
single sport. Baseball is rife with cases 
of the so-called Tommy John surgery 
for pitchers who have worn out or torn 
the ulnar collateral ligament in their 
elbows. Among soccer players, Menon 
sees both overuse and acute injuries.
The resiliency and determination of 
athletes continues to impress Menon. He 
cites the example of a Rays pitcher who 
underwent Tommy John surgery a year 
ago. While participating in the extensive 
rehab, and essentially putting his life and 
career on hold for more than a year, the 
pitcher suffered a major setback during 
a throwing session when his medial 
epicondyle tore off. Another surgery with 
a lengthy rehab was required.
“What was so remarkable was how 
composed and deliberate the player was 
about the whole event,” Menon recalls. 
“The hallmark of a true professional 
competitor is seeing each challenge as 
just part of the game. He told me he was 
ready to get the procedure done so he 
could get back to where he needed to be.”
Menon’s job is to get players back 
on the field — not to talk about it. He 
admires his patients. “The best thing 
about working with athletes is their 
drive and their love of sports,” he says.  
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A s a student, Emily Kavanaugh started down the path of nursing, picking up fundamental courses as she strode toward her future. But two consecutive summer internships tempted her off the trail.
“Since about 2007, when I first interned at a clinical 
research facility, I knew that I wanted to do something with 
research,” says Emily. “It fascinated me.”
The research during her internships, she explains, 
focused on Alzheimer’s disease. One patient, “Shep,” 
showed signs of progress; the first summer Emily was there, 
he didn’t recognize his family, but by the second summer, he 
was chatting about his granddaughter. “That was my turning 
point: realizing that you have a direct impact on someone’s 
life in that way for future generations,” Emily says. Not long 
after, she decided to enroll in the online bachelor’s degree 
completion program in the Clinical Research Administration 
IT’S GENETIC: 
Mother and Daughter  
Pursue a Health Sciences 
Education Track Together
(CRA) track at GW’s School of Medicine and Health Sciences 
(SMHS). And she wasn’t alone.
Gina Kavanaugh, like her daughter, was on a nursing 
path. After many years working as a registered nurse, Gina 
made the jump to research. “I’ve been involved in clinical 
research for 15 years,” Gina says. “That’s really where my 
love has evolved.” As she ascended in her field — rising to 
director of research at the facility where Emily interned — 
Gina realized further career advancement required earning 
her bachelor’s degree in clinical research. In an industry as 
degree-conscious as clinical research, there is a constant 
demand to keep pace through higher education and 
ongoing training. Gina, like Emily, enrolled in GW’s Bachelor 
of Science in Health Sciences degree program in CRA.
“When I started out in the field, there was very little 
formal training for a coordinator,” explains Gina. “Most of the 
education on the process was provided by the pharmaceu-
tical companies conducting the trials. I was very excited to 
find such an excellent program of study at GW.”
The SMHS program focuses on drug development and 
the various aspects of managing clinical trials and outcomes. 
It’s a profession, says Joan Butler, Ed.D. ’09, program 
director for the academic undergraduate and graduate 
online CRA programs and assistant professor in the 
Department of Clinical Research and Leadership at SMHS, 
that appeals to those passionate about research.
“One of the overriding aspects that really draws 
students to this career is the fact that they’re helping patients 
by discovering new treatments and therapies that allow them 
to effectively treat their unmet medical needs,” says Butler.
Gina and Emily Kavanaugh describe their experience as 
classmates in the program with the same word: awesome. 
The two are friendly competitors of sorts; academically, 
they strive to outdo each other on tests and assignments, 
and Gina’s grade point average is one-tenth of a point 
higher than Emily’s — for now. They also rely on each other’s 
strengths. “The whole online learning [approach] was a bit 
of a learning curve within itself,” Gina says, “so I was really 
hoping [Emily] would be able to help me make that transition 
and get back into that mindset of school.”
The program has allowed the two to remain in greater 
contact, though they live on opposite sides of Virginia: 
Gina is in Newport News, where she’s now the director 
of research and discovery for Riverside Health System; 
Emily, a college recruitment representative at the Jefferson 
College of Health Sciences, lives in Roanoke. The two talk 
shop whenever they can — even at holiday dinners, much to 
the family’s dismay.
With their first year completed, Emily and Gina are 
contemplating future plans, but more immediately, they’re 
anticipating the graduation ceremony. “That’s the one thing 
we’re really looking forward to,” Emily says. “I think that 
would be so special [to do together].”  
STUDENT PROFILE
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S tuart Portnoy,  M.D. ’91, RESD ’92, has just returned from a trip to Germany and Austria with his family. His itinerary is colorful and neatly laid out in a docu-ment on his laptop, though he clicks from it to other 
items, including a map of another trip, this one to Vietnam 
in April. The September before he was in Malaysia, and a 
year before that his destination was Singapore. This latest 
passage abroad was personal; the others, business.
“It’s so much fun for me to be [in Southeast Asia],” 
Portnoy says, “and I love traveling.”
Although his trips are recent, the story behind them 
stretches back years. Portnoy’s journey began as a young 
student. “From the time I was at GW medical school — I’d 
already studied chemical engineering as an undergraduate 
— I knew during Year One that I wanted to do something at 
the intersection of medicine and technology,” he says. 
With that convergence in mind, Portnoy wrote GW to 
delay his enrollment by one year so that he could study 
biomedical engineering in Israel. GW said yes.
“It was so refreshing,” Portnoy recalls. “I knew by the end 
of that year that I wasn’t going to be a traditional physician.”
When Portnoy returned to the United States, he settled 
into the GW environment but took another yearlong break, 
this time to earn a master’s degree in bioengineering at the 
University of Pennsylvania. “I loved it so much,” he says.
As both an M.D. and an engineer, Portnoy took what he 
describes as a “unique career path.” He spent eight years 
with the U.S. Food and Drug Administration (FDA) before 
turning to consulting with Biologics Consulting Group; his 
area is medical device regulation for cardiology-specific 
instruments. With his extensive clinical and FDA-based regu-
latory experience, Portnoy became an appealing candidate 
for the missions that would take him overseas. That story 
begins about two decades ago.
Back in the 1990s, according to Matthew Hein, 
international trade specialist for the U.S. Department of 
Commerce’s International Trade Administration (ITA), the 
European Union, Canada, Australia, Japan, and the United 
States formed the Global Harmonization Task Force on 
Medical Devices (GHTF), which created guidance docu-
ments for medical device regulatory regimes. Southeast 
Asia, lacking established regimes, became a region of great 
interest. As a result, the Association of Southeast Asian 
Nations began to implement its systems using both the 
GHTF documents and guidance from international regula-
tors — including FDA alumnus Portnoy.
“It’s a perfect partnership between people like me, an 
FDA alum, and what the Department of Commerce and the 
host nations are looking for,” Portnoy says.
He visited Singapore separately in 2013 to consult about 
his experience with FDA and then joined the ITA initiative. 
In 2014 and 2015, he went to Malaysia and Vietnam, respec-
tively, to present at ITA-organized workshops with other 
industry trainers. In Vietnam, Portnoy spoke about clinical 
evidence, although the learning and valuable interactions, 
he says, went both ways.
“I think the best part is spending time with my peer 
group,” Portnoy says. “People who I didn’t know before that 
I really love to talk shop with, talk professional, talk families, 
talk about what companies they’ve worked at before. That’s 
number one. Number two, I am learning. I am learning new 
things all the time, which is great for me.”
Portnoy intends to return to Southeast Asia, where he’s 
enthusiastic about the regulatory regime developments. “It’s 
a win-win-win, no matter how you look at it,” Portnoy says. “I 
just love it from start to finish.”  
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From GW to Southeast Asia
SMHS alumnus taps into clinical and  
FDA expertise to help nations in Southeast Asia 
implement medical device regulatory regimes
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1950s
Adolphe C. Kiczales, M.D. ’55, A.A. ’49, recently retired after 
55 years practicing psychiatry. He and his wife, Barbara, live 
in West Virginia. 
1960s
Vincent T. DeVita Jr., M.D. ’61, Hon. ’84, co-wrote The 
Death of Cancer (Sarah Crichton Books, 2015) with his 
daughter, Elizabeth DeVita-Raeburn. The former director 
of the National Cancer Institute, former physician-in-chief 
at Memorial Sloan Kettering, director of the Yale Cancer 
Center, former president of the American Cancer Society, 
and developer of the first successful chemotherapy treat-
ment for Hodgkin’s lymphoma shares a first-person account 
of the continued fight against cancer. 
Seymour Gendelman, M.D. ’64, who has directed the Mount 
Sinai neurology residency program for the past 15 years, was 
named Professor Emeritus, Department of Neurology, Mount 
Sinai Medical Center in New York City upon his retirement on 
Jan. 1, 2015. Gendelman is a lifetime member of the World 
Federation of Hemophilia. He has written many papers relating 
to the neurologic complications of hemophilia. In his free time, 
Gendelman trained for and ran the New York City Marathon.
Leading the Pack
Denice Cora-Bramble, M.D., M.B.A., B.S. ’76, FAAP, was 
named executive vice president and chief medical officer for 
ambulatory and community health service and senior vice 
president for the Goldberg Center for Community Pediatric 
Health at Children’s National Health System. In her new role, 
Cora-Bramble leads all the regional ambulatory clinical 
operations; oversees a $113 million budget; and guides 
physicians, nurses, and administrative staff members. She 
also heads the physician business enterprise at Children’s 
National, as well as the strategic alliance and vaccine group 
purchasing contracts, among other responsibilities, with 
the Children’s National Health Network, a provider group of 
more than 1,400 community-based pediatricians.
Cora-Bramble, a professor of pediatrics at the GW 
School of Medicine and Health Sciences, has held leader-
ship roles at both GW and the U.S. Department of Health 
and Human Services. She is a diplomate of the American 
Board of Pediatrics, and in 2007, she received the highest 
national honor in community pediatric education, the 
Academic Pediatric Association and the American Academy 
of Pediatrics’ National Pediatric Community Teaching Award.
Creating a 
 Meaningful Legacy at GW is 
 easy.
 
If you have a retirement plan, it’s easy to help deserving students receive a world-class 
medical education. You can name the GW School of Medicine and Health Sciences 
as a beneficiary of some or all of the funds that may remain in your IRA, 401(k), 
or other plan after your lifetime. Just complete a new beneficiary designation form 
that includes the GW School of Medicine and Health Sciences and its Tax ID number 
(53-0196584) and submit it to your plan administrator.
A few of the benefits: 
Flexibility to support the SMHS program of your choice.
No change in lifestyle since your gift comes from leftover funds. 
Elimination of income and estate taxes that otherwise would be due. 
We can answer your questions to  
help make it even easier. Contact us today!
CALL: 877-498-7590 
EMAIL: pgiving1@gwu.edu 
ONLINE: go.gwu.edu/plannedgiving
Dr. Ellis is supporting the GW School of Medicine 
and Health Sciences with a gift of $100,000 through 
his IRA. His estate will receive a significant tax 
deduction and GW will receive the designated 
portion of his IRA tax-free.
“As I enjoy retirement, I continue to 
reflect on GW - the place where it all 
started. Through my estate planning, 
I’m doing my part to ensure that the 
dream I lived can be realized by others 
in the future.”     – George Ellis, MD ‘56
DAR2106
1970s
Culley Carson III, M.D. ’71, FACS, Rhodes Distinguished 
Professor of Urology and former chief of urology at the 
University of North Carolina at Chapel Hill, received the 
2014 St. Paul’s Medal from the British Association of Urologic 
Surgeons. Carson also received the 2015 Massachusetts 
Medical Society Men’s Health Award during the society’s 
13th Annual Symposium on Men’s Health. 
Dennis Michael Dimitri, M.D. ’79, vice chair and clinical asso-
ciate professor of family medicine and community health, 
University of Massachusetts Memorial Medical Center, was 
elected president of the Massachusetts Medical Society. 
1980s
Lisa Murray, M.D. ’86, RESD ’87, was promoted to medical 
director at the student health center at Towson University in 
Maryland. Previously, she served as physician and medical 
staff coordinator for the 22,000-student public university.
1990s
Nicole DeIorio, M.D. ’96, RESD ’00, was recently promoted 
to professor of emergency medicine and assistant dean of 
student affairs for the Oregon Health and Science University 
School of Medicine. Delorio, who also serves as director of 
medical student education in the Department of Emergency 
Medicine, will serve as a member of the undergraduate 
medical education leadership team and will be integral to 
supporting all students in the M.D. program.
Leesa M. Galatz, M.D. ’93, RESD ’04, an expert in surgery 
for traumatic and degenerative disorders of the shoulder 
and elbow, was selected to serve as the system chair of 
the Department of Orthopaedics at the Icahn School of 
Medicine at Mount Sinai. 
Dennis Rivenburgh, PA-C ’97, was named program director 
of the Anne Arundel Community College/University of 
Maryland-Baltimore Physician Assistant Program.
2000s
Lindsay Marsh Warren, M.D. ’02, RESD ’06, B.A. ’98, 
received the GW Black Alumni Association’s 2015 IMPACT 
Award on Sept. 26. The honor, entering its 10th year, is the 
highest form of recognition bestowed on distinguished 
black alumni at the university.
Nihar Patel, M.D., RESD ’08, a hematology 
and oncology specialist, recently joined the medical staff at 
Willis-Knighton Cancer Center and Hematology/Oncology 
Associates. Patel completed a residency and fellowship in 
medical oncology and hematology at SMHS.
Floyd D. Loop, M.D. ’62, RESD 
’68, a world-renowned heart 
surgeon, former chair and 
CEO of the Cleveland Clinic, 
passed away in June 2015 at 
the age of 78. Loop, whose 
initiation into medicine traced 
back to his father’s practice in 
rural Indiana, graduated from 
Purdue University in 1958 and 
GW in 1962. He served in the United States Air Force before 
training in cardiothoracic surgery at the Cleveland Clinic on 
the advice of Brian Blades, M.D., a former Lewis B. Saltz Chair 
of Surgery at GW. “That was a defining moment,” Loop told 
Medicine + Health in 2013 of his decision to participate in the 
clinic’s cardiac program. There, Loop performed thousands 
of heart surgeries and assembled a team of thoracic and 
cardiovascular surgeons, who elevated the clinic’s reputation 
and helped pioneer surgical techniques and innovations. 
After accepting a staff position in 1970, Loop became chair 
of cardiothoracic surgery at the Cleveland Clinic in 1975. During 
his tenure, he crafted the clinic into a profitable top hospital for 
heart surgery and expanded its footprint, constructing ambula-
tory facilities across the state and an additional medical center 
in Florida. Loop was responsible for improving preoperative 
techniques, arterial grafting, and valve repair, and he helped 
launch a computerized registry of cardiac surgery results.
Loop, who retired from surgery in 1999, received 
numerous awards and honors, including the American 
College of Cardiology Cummings Humanitarian Award, the 
American Heart Association Citation for International Service, 
and the Cleveland Clinic Lerner Humanitarian Award.
Associate Clinical Professor Emeritus of Medicine Warren 
Daniel Brill, M.D., passed away Sept. 14, 2015, at age 94. 
A native Washingtonian and graduate of Central High 
School and the University of Maryland, where he earned his 
Bachelor of Science and Doctor of Medicine degrees in 1941 
and 1943 respectively, Brill practiced internal medicine in 
Washington, D.C. for 45 years. He served as a professor of 
medicine at GW’s School of Medicine and Health Sciences 
for more than 30 years, and after his retirement he continued 
to guide GW M.D. program students as a volunteer, 
teaching patient history and physical examination. He was 
a past president of the D.C. Medical Society, a member of 
the Jacobi Medical Society, and a fellow of the American 
College of Physicians. Brill is survived by his wife of 70 years, 
Bess, and their three children, eight grandchildren, and two 
great-grandchildren.
IN MEMORIAM 
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Judson G. Randolph, M.D., 
renowned GW School 
of Medicine and Health 
Sciences (SMHS) 
professor and nation-
ally recognized leader 
in pediatric surgery, 
passed away on May 
17, 2015, in Nashville, 
Tennessee, at the age 
of 87. Randolph was 
born July 9, 1927, in 
Macon, Georgia, and 
grew up in Nashville. After serving in the Navy from 1945 
to 1946, Randolph returned to his hometown to attend 
Vanderbilt University; he graduated from the school in 1950 
and earned his medical degree from Vanderbilt’s medical 
school in 1953. 
Before joining the GW faculty as a professor of 
surgery and pediatrics in 1963, he trained in surgery at 
Massachusetts General Hospital and Boston Children’s 
Hospital. He was also a faculty member at Harvard Medical 
William V. Applegate, M.D. ’57
Frank Thomas Barranco Sr., M.D. ’56
Jeanne Barinott Bradley, M.D. ’51, 
RESD ’52 
John Grover Bradley, M.D. ’51, RESD ’52
Milton H. Brinton, M.D. ’77
Richard Carlisle, M.D. ’65
Sheridan L. Daines, M.D. ’65
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C. Richard Gill, M.D. ’55
Ebrahim Navid, M.D., RESD ’67 
Joseph E. Rawlings, M.D. ’53, B.A. ’50
Jerome V. Rose, M.D. ’45
Jimmy Lynn Stubblefield, PA ’99
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Ozgur Ekmekci, Ed.D., M.B.A., faculty 
member in GW’s School of Medicine 
and Health Sciences Department of 
Clinical Research and Leadership since 
2007, passed away Sept. 19, 2015, 
following a heart attack. 
Ekmekci, an associate professor of 
clinical research and leadership, served 
as the interim chair of the department 
from 2013 to 2015. Under his leader-
ship, the department grew to offer 
nearly a dozen programs in addition 
to many military contract specialty 
programs. He served as the program 
director for the Health Care Quality 
Master’s Degree Program from 2007 
to 2013, where he provided strategic 
leadership in an area of significant 
growth. 
During his time as a leader in the 
health sciences, Ekmekci continued 
to conduct research in and teach 
graduate-level courses in leadership, 
organizational change, health informa-
tion technology, health care quality, 
School. The year he arrived at GW, Randolph started his 
25-year tenure as surgeon-in-chief at what is now Children’s 
National Health System (Children’s National).
“Dr. Randolph was one of the giants of American 
surgery,” said Anton Sidawy, M.D., M.P.H., Lewis B. Saltz 
Chair of the Department of Surgery and professor of surgery 
at SMHS. “He trained over 40 fellows in pediatric surgery, 
many of whom assumed leadership positions in prestigious 
institutions around the country. In addition, he introduced 
hundreds of surgical residents to pediatric surgery and 
inspired them to pursue academic careers of their own; I 
was one of those residents. He was a spectacular surgeon, a 
dedicated mentor, and a passionate leader who always put 
his patients first. He will certainly be missed by his friends, 
colleagues, and trainees.”
Among his many accomplishments, Randolph was 
a former chair of the surgical section of the American 
Academy of Pediatrics, president of the American Pediatric 
Surgical Association, and founder of the American Board of 
Surgery’s pediatric committee. Following his retirement from 
Children’s National, the Judson G. Randolph Fellowship in 
Pediatric Surgery was established in his honor.
learning evaluation, and research 
methods. His research interests 
centered on interprofessional educa-
tion (IPE), organizational identification, 
professional identity, and agent-based 
modeling. Ekmekci had recently 
completed a yearlong study to develop 
a method to evaluate learning and 
performance in IPE teams. The project 
built upon an earlier study on IPE, 
published in 2013 in the Journal of the 
Allied Health Professions, that showed 
a “significant increase in teamwork and 
leadership” after executive coaching 
and simulation. 
Senior Associate Dean for Health 
Sciences Joe Bocchino, Ed.D., M.B.A., 
described Ekmekci as a “remark-
able person, a wonderful friend, an 
outstanding teacher, and a terrific 
member of the faculty. As a testament 
to the high regard that his colleagues 
and students had for him, Ekmekci 
was awarded the university’s Bender 
Teaching Award in 2011.” 
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IN DEVELOPMENT
B
ecause academic medicine makes a profound impact 
on the quality of life and the state of knowledge, it 
historically has attracted significant philanthropic 
gifts. That continues today as medical schools and 
teaching hospitals in the United States have received news-
worthy seven- and eight-figure gifts in 2015. There have even 
been incredible nine-figure commitments, for instance, to the 
Memorial Sloan Kettering Cancer Center.
Often these gifts come from the hands of grateful patients 
or their families, from regional business leaders or alumni. 
Always the gifts come because of the demonstrable excellence 
of the results, innovation, and vision embodied in the recipient. 
Great programs, great ideas, and great people attract great 
philanthropy.
Cancer, neuroscience, and transplantation, three of GW’s 
rapidly expanding areas of clinical and research innovation, are 
highlighted in this issue of Medicine + Health. Will one of them 
inspire a visionary benefactor to emerge and make a magnifi-
cent gift to the School of Medicine and Health Sciences? Now 
is the opportune time, because our physicians, scientists, and 
professional staff are ready to make history as never before.
Sincerely,
Dennis Narango, M.A., C.F.R.E.
Associate Dean, SMHS and Associate Vice President for GW 
Medicine Development and Alumni Relations
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Dermatology; Professor of Dermatology, Johns Hopkins University; 
Former Member, GW Board of Trustees
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Sciences, SMHS; Private Practice
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A COMPREHENSIVE CANCER VISIONARY
Renowned lymphoma researcher Eduardo Sotomayor, M.D., Ph.D., came to GW’s School of Medicine 
and Health Sciences for one purpose: to build a premier cancer center that excels in research, clinical 
investigations, prevention/control policy, and patient education and outreach. Read more on page 14.
